Composition comprising antimicrobial agent and alkyl ketal ester compound
By using alkyl ketal ester compounds in synergistic with antimicrobial agents, the problem of broad-spectrum antimicrobial activity against various microorganisms in cosmetics, pharmaceuticals, and food has been solved, achieving a more efficient and safer microbial inhibition effect.
Patent Information
- Application Number
- CN202280094941.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2022-04-22
- Publication Date
- 2024-11-26
AI Technical Summary
There is a lack of effective and safe antimicrobial agents in existing cosmetics, pharmaceuticals and foods. They are difficult to show broad-spectrum antimicrobial activity against a variety of microorganisms such as bacteria, yeast and mold under different pH values and environments, and traditional preservatives may cause side effects or instability.
The synergistic combination of alkyl ketal compounds, such as ethyl levulinate propylene glycol acetal, and antimicrobial agents creates a synergistic antimicrobial effect, enhancing antimicrobial efficacy against a variety of microorganisms, such as Staphylococcus, Candida, and Aspergillus.
It achieves synergistic inhibition and stability of multiple microorganisms in cosmetics, pharmaceuticals and food, reduces the risk of microbial contamination, and improves product shelf life and safety.
Smart Images

Figure BDA0005086877500000041 
Figure BDA0005086877500000051 
Figure BDA0005086877500000061
Abstract
Description
Technical Field
[0001] The present invention relates to a composition comprising or consisting of a synergistic combination of an effective amount of an antimicrobial agent and an effective amount of an alkyl ketal ester compound. In another aspect, the present invention relates to a novel antimicrobial substance. In addition, the present invention relates to a food, cosmetic or pharmaceutical preparation or a home care product comprising the composition. In addition, the present invention relates to the use of the composition or the novel antimicrobial substance for preventing or inhibiting the growth of microorganisms in food, cosmetic or pharmaceutical preparations or home care products. In addition, the present invention relates to the use of alkyl ketal ester compounds, in particular ethyl levulinate propylene glycol acetal and / or ethyl levulinate glycerol acetal for enhancing the efficacy of antimicrobial agents. Finally, the present invention relates to a method for preventing or inhibiting the growth of microorganisms in food, cosmetic or pharmaceutical preparations or home care products by the composition or by the novel antimicrobial substance. Background Art
[0002] Food, cosmetics, pharmaceuticals or household care products offer an optimal medium for microbial contamination: with proteins, sugars, vitamins, oils and water, they contain all the substances necessary for the growth of microorganisms. In particular, cosmetic or pharmaceutical formulations with a high water content and / or a large surface, such as lotions or wipes, or formulations with natural ingredients, which are inherently contaminated with bacteria, are sensitive to microbial growth. Neutral pH and storage in warm, humid bathrooms help to provide an ideal climate for bacteria and molds. Through hands and mouth, many microorganisms enter the product. Sometimes the product is already contaminated during the production process, for example by contaminated raw materials. Most microorganisms are harmless to the consumer. However, microbial contaminants can cause dangerous infections. In addition, some molds and bacteria produce toxins, which can cause allergic reactions and skin irritation.
[0003] In order to minimize microbial contamination, preservatives are used. Preservatives are essential in cosmetic production because they kill or inhibit the growth of microorganisms. Without adequate preservation, this in turn can lead to product spoilage, which in cosmetics can manifest as odor change, discoloration, mold growth, gas formation, emulsion separation or viscosity changes, making the product unacceptable to consumers.
[0004] Preservatives, especially antimicrobials, are therefore very important to prevent cosmetics from spoiling and inhibiting the growth of potentially dangerous microorganisms. However, not all substances that can be used as preservatives are harmless to consumers. For example, parabens have hormonal effects; benzoic acid can cause pseudoallergic reactions. The German Cosmetics Regulation lists all preservatives that are allowed in cosmetics.
[0005] In addition, there are several natural materials that contain substances that are said to have antimicrobial effects. These include, for example, propolis, cinnamon bark, clove oil, allspice oil, nutmeg oil, ylang-ylang, rose oil, and thyme. However, these substances have not been fully investigated for use as preservatives in the cosmetics industry.
[0006] Currently, there are no legally binding limits for bacterial content in cosmetics. According to the Scientific Committee on Consumer Safety of the European Commission, cosmetics should contain no more than 100 or 1,000 colony-forming units per gram, depending on the type of product. Certain pathogens such as Staphylococcus or E. coli are not allowed to be detected at all.
[0007] Therefore, both in the cosmetic and pharmaceutical industry and in the food industry or the home care business / market, there is a continuous need for agents with antimicrobial properties for product protection.
[0008] Indeed, a number of antimicrobial active substances are already used in the technical field in question, but alternatives are still being sought in order to enable targeted special treatments and / or to reduce side effects. In this context, however, when looking for alternative agents with an antimicrobial and, in particular, preservative effect, it must be taken into account that the substances used in the cosmetic, pharmaceutical and / or food sectors must be
[0009] ●Toxicologically acceptable;
[0010] ●Good skin tolerance;
[0011] ● stable (especially in conventional cosmetic and / or pharmaceutical formulations);
[0012] • substantially and preferably completely odorless; and
[0013] • Can be prepared inexpensively (ie using standard methods and / or starting from standard precursors) and be of natural origin or based on green synthesis.
[0014] For the person skilled in the art, the search for suitable (active) substances which possess one or more of the properties mentioned to a sufficient extent is made more difficult by the fact that there is no clear dependency between the chemical structure of a substance on the one hand and its biological activity against specific microorganisms (germs) and its stability on the other hand. Furthermore, there is no predictable relationship between antimicrobial action, toxicological acceptability, skin tolerance and the stability of a substance.
[0015] Furthermore, antimicrobial agents should have antimicrobial activity characteristics that meet different criteria. They should
[0016] ●Provides broad-spectrum antimicrobial activity against Gram-positive and Gram-negative bacteria, yeasts, molds, and fungi;
[0017] ● Shows particularly strong activity against Candida and Aspergillus; and
[0018] ● Active in different cosmetic or pharmaceutical formulations, especially at different pH values.
[0019] According to the biocide legislation, the addition of biocides, in particular classic preservatives such as formaldehyde donors, is increasingly undesirable, in particular for natural cosmetics.
[0020] Sterilization of formulations is less desirable due to the potential degradation of formulation ingredients upon heat treatment and the additional processing costs involved.
[0021] Therefore, there is still a continuing need to provide novel substances or compositions that meet the above requirements and are microbiologically stable during the shelf life. The cosmetic or pharmaceutical industry as well as the food industry and the home care industry are constantly looking for ingredients that can improve these aspects. In particular, there is a continuing interest on the market to improve the potential and efficacy spectrum of antimicrobial substances by achieving a higher performance of the antimicrobial substance with the same amount, or vice versa, by achieving the same performance with a lower amount of antimicrobial substance, so that the total content of antimicrobial substances in ready-to-use formulations can be reduced.
[0022] The object of the present invention is therefore to provide a composition which has a synergistic effect on a variety of bacteria, yeasts, molds and fungi, in particular in food, cosmetic or pharmaceutical preparations or household products, and its use, by which the activity or growth of microorganisms can be prevented or inhibited.
[0023] Furthermore, it was an object of the present invention to provide novel antimicrobial compounds.
[0024] Furthermore, the object of the present invention is to provide a food, cosmetic or pharmaceutical preparation or a household care product comprising the composition or the novel antimicrobial substance according to the present invention.
[0025] Furthermore, it was an object of the present invention to provide a substance by means of which the antimicrobial efficacy of antimicrobial agents can be enhanced.
[0026] Furthermore, it was an object of the present invention to provide a method for preventing or inhibiting the growth of microorganisms in foods, cosmetic or pharmaceutical preparations or household care products.
[0027] The present invention is based on the surprising discovery that the concomitant use of an effective amount of an alkyl ketal ester compound as defined herein, in particular ethyl levulinate propylene glycol acetal and ethyl levulinate glycerol acetal, with an antimicrobial agent achieves a synergistic antimicrobial effect against a variety of microorganisms such as bacteria, yeasts, molds and fungi. The use of such a composition in food, cosmetic or pharmaceutical preparations or household care products in turn results in a microbiologically stable formulation that can be stored. Surprisingly, the synergistic antimicrobial effect is against species of the genera Staphylococcus, Candida, Aspergillus, Pseudomonas and Escherichia and combinations thereof.
[0028] Additionally, it has been surprisingly found that certain alkyl ketal ester compounds as defined herein have antimicrobial efficacy against species of Staphylococcus, Candida, Aspergillus, Pseudomonas and Escherichia, and combinations thereof. Summary of the invention
[0029] In order to achieve the above problem, the present invention provides a composition in the first aspect, which comprises or consists of the following:
[0030] (a) an effective amount of at least one antimicrobial agent;
[0031] (b) an effective amount of an alkyl ketal ester compound represented by the general formula (I) or a derivative thereof
[0032]
[0033] in
[0034] R 1 is an optionally substituted C1 to C12 alkyl group or an optionally substituted C1 to C12 alkenyl group;
[0035] R 2 is hydrogen, optionally substituted C1 to C3 alkyl or optionally substituted C1 to C3 alkenyl;
[0036] R 3 , R 4 , R 5 , R 6 and R 7 are each independently hydrogen, optionally substituted C1 to C6 alkyl, or optionally substituted C1 to C6 alkenyl;
[0037] a is 0 or an integer from 1 to 6;
[0038] b is 0 or 1;
[0039] as well as
[0040] (c) optionally at least one active substance and / or additive for a food, cosmetic or pharmaceutical composition or a household care product.
[0041] In a second aspect, the present invention provides an antimicrobial compound represented by general formula (I) or a derivative thereof
[0042]
[0043] in
[0044] R 1 is an optionally substituted C1 to C12 alkyl group or an optionally substituted C1 to C12 alkenyl group;
[0045] R 2 is hydrogen, optionally substituted C1 to C3 alkyl or optionally substituted C1 to C3 alkenyl;
[0046] R 3 , R 4 , R 5 , R 6 and R 7 are each independently hydrogen, optionally substituted C1 to C6 alkyl, or optionally substituted C1 to C6 alkenyl;
[0047] a is 0 or an integer from 1 to 6;
[0048] b is 0 or 1.
[0049] In another aspect, the present invention provides a food, cosmetic or pharmaceutical preparation or a household care product comprising the antimicrobial composition or the novel antimicrobial substance according to the present invention.
[0050] In another aspect, the present invention provides use of the antimicrobial composition or the novel antimicrobial substance according to the present invention for preventing or inhibiting the growth of microorganisms in food, cosmetics or pharmaceutical preparations.
[0051] In a further aspect, the present invention provides the use of an alkyl ketal ester compound as defined herein for enhancing the efficacy of an antimicrobial agent.
[0052] In a final aspect, the present invention provides a method of preventing or inhibiting the growth of microorganisms in a food, cosmetic or pharmaceutical preparation or household care product by means of an antimicrobial composition or antimicrobial substance according to the present invention.
[0053] The present invention is described in detail in the appended claims. However, the present invention itself and its preferred variations, other objects and advantages are also apparent from the following detailed description in conjunction with the appended embodiments and drawings. DETAILED DESCRIPTION
[0054] In a first aspect, the present invention relates to a composition comprising or consisting of:
[0055] (a) an effective amount of at least one antimicrobial agent;
[0056] (b) an effective amount of an alkyl ketal ester compound represented by the general formula (I) or a derivative thereof
[0057]
[0058] in
[0059] R 1 is an optionally substituted C1 to C12 alkyl group or an optionally substituted C1 to C12 alkenyl group;
[0060] R 2 is hydrogen, optionally substituted C1 to C3 alkyl or optionally substituted C1 to C3 alkenyl;
[0061] R 3 , R 4 , R 5 , R 6 and R 7 are each independently hydrogen, optionally substituted C1 to C6 alkyl, or optionally substituted C1 to C6 alkenyl;
[0062] a is 0 or an integer from 1 to 6;
[0063] b is 0 or 1;
[0064] as well as
[0065] (c) optionally at least one active substance and / or additive for a food, cosmetic or pharmaceutical composition or a household care product.
[0066] The term "comprising" means that the specified components are essential to the composition, but other components may be added and still be included in the present invention.
[0067] The term "consisting of" as used in accordance with the present invention means that the total amount of components (a) through (c) add up to 100 weight percent, based on the total weight of the composition, and indicates that the subject matter is closed and may include only the limitations explicitly recited.
[0068] Whenever "comprising" is mentioned, it is intended to encompass both meanings as alternatives, ie the meaning may be "including" or "consisting of", unless the context dictates otherwise.
[0069] The term "at least one ..." means that the composition according to the invention may comprise one or a mixture of two, three, four, five, six or even more of the respective components following the term.
[0070] The term "optionally" means that the subsequently described component may but need not be present in the composition, and that the description includes variations in which the compound is included and variations in which the compound is not present.
[0071] The term "effective amount of" in the context of the present invention means an amount of a compound sufficient to provide the desired effect, such as an antimicrobial effect, a synergistic effect, and the like.
[0072] As used herein, the term "alkyl" or "alkyl group" refers to a saturated hydrocarbon having one or more carbon atoms, including straight-chain alkyl groups (e.g., methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl, etc.), cycloalkyl groups (e.g., cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, etc.), branched alkyl groups (e.g., isopropyl, tert-butyl, sec-butyl, isobutyl, etc.), and alkyl-substituted alkyl groups (e.g., alkyl-substituted cycloalkyl groups and cycloalkyl-substituted alkyl groups).
[0073] Preferred alkyl groups include C1 to C6 alkyl groups including methyl, ethyl, propyl, 1-methylethyl, butyl, 1-methylpropyl, 2-methylpropyl, 1,1-dimethylethyl, pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 2,2-dimethylpropyl, 1-ethylpropyl, hexyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1-ethylbutyl, 2-ethylbutyl, 1,1,2-trimethylpropyl, 1,2,2-trimethylpropyl, 1-ethyl-1-methylpropyl and 1-ethyl-2-methylpropyl.
[0074] Unless otherwise stated, the term "alkyl" includes "unsubstituted alkyl" and "substituted alkyl".
[0075] As used herein, the term "substituted alkyl" refers to an alkyl group having substituents replacing one or more hydrogens on one or more carbon atoms of the hydrocarbon backbone. Such substituents may include, for example, OH, halogen (Cl, Br, I), alkenyl, alkynyl, alkylcarbonyloxy, arylcarbonyloxy, alkoxycarbonyloxy, aryloxy, aryloxycarbonyloxy, carboxylate, alkylcarbonyl, arylcarbonyl, alkoxycarbonyl, aminocarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, alkylthiocarbonyl, alkoxy, phosphate, phosphonate, phosphinate, cyano, amino (including alkylamino, dialkylamino, arylamino, diarylamino and alkylarylamino), acylamino (including alkylcarbonylamino, arylcarbonylamino, carbamoyl and ureido), imino, sulfhydryl, alkylthio, arylthio, thiocarboxylate, sulfate, alkylsulfinyl, sulfonate, sulfamoyl, sulfonamido, nitro, trifluoromethyl, cyano, azido, heterocyclic, alkylaryl or aromatic (including heteroaromatic) groups.
[0076] In some embodiments, substituted alkyl groups may include heterocyclic groups.
[0077] As used herein, the term "heterocyclic group" includes a closed ring structure similar to a carbocyclic group, wherein one or more carbon atoms in the ring are non-carbon elements, such as nitrogen, sulfur or oxygen. The heterocyclic group can be saturated or unsaturated. Exemplary heterocyclic groups include but are not limited to aziridine, ethylene oxide (epoxide, oxirane), thiirane (epoxysulfide), dioxirane, azetidine, oxetane, thiamine, dioxetane, dithiamine, dithiamine (dithiete), azolidine, pyrrolidine, pyrroline, oxolane, dihydrofuran and furan.
[0078] In a preferred variation, the alkyl group is unsubstituted.
[0079] An alkenyl group or alkene is a straight chain, branched or cyclic alkyl group having two to about 12 carbon atoms and also including at least one double bond. In some embodiments, the alkenyl group has 2 to about 10 carbon atoms, or typically 2 to 5 carbon atoms.
[0080] Unless otherwise stated, the term "alkenyl" includes "unsubstituted alkenyl" and "substituted alkenyl".
[0081] Alkenyl groups may be substituted similarly to alkyl groups as defined above.
[0082] In a preferred variation, the alkenyl group is unsubstituted.
[0083] As used herein, the terms "alkylene," "cycloalkylene," "alkynylene," and "alkenylene," by themselves or as part of another substituent, refer to a divalent radical derived from an alkyl, cycloalkyl, or alkenyl group, respectively, as exemplified by -CH2CH2CH2-.
[0084] Component (a) in the composition according to the first aspect of the invention relates to an antimicrobial agent or compound which is commonly used in food and many cosmetic preparations, in particular skin care, hair care or body care, or in pharmaceutical preparations.
[0085] In the context of the present invention, the term "antimicrobial" or "antimicrobial compound" refers to a group of substances, in particular agents that kill microorganisms or stop or inhibit their growth. Antimicrobials can be grouped according to the microorganisms on which they primarily act. For example, antibiotics are used against bacteria, antifungals are used against fungi, antiprotozoa are used against protozoa, and antivirals are used against viruses. They can also be classified according to their function. Agents that kill microorganisms are biocides or microbicides, while those that only inhibit their growth are called biostatics.
[0086] The antimicrobial agents according to the present invention act primarily against microorganisms, particularly bacteria, yeasts and / or fungi. Specific microorganisms are undesirable aerobic mesophilic bacteria or yeasts or fungi in cosmetics, which may be harmful to human health or serve as an indication of sanitary failure in the manufacturing process. Microorganisms considered as specific microorganisms according to the present invention belong to the genera Pseudomonas (bacteria), Staphylococcus (bacteria), Escherichia (bacteria), Candida (yeast) and Aspergillus (fungi), and combinations thereof.
[0087] More preferably, the microorganism is selected from the group consisting of Pseudomonas aeruginosa, Staphylococcus aureus, Escherichia coli, Candida albicans and Aspergillus brasiliensis and combinations thereof.
[0088] The composition according to the first aspect of the present invention comprises at least one antimicrobial active agent selected from o-cymene-5-ol, isopropyl paraben, capryloyl glycine, phenylpropanol, tropolone, PCA cocoyl arginine ethyl ester salt, 2-methyl-5-cyclohexylpentanol, phenoxyethanol, disodium EDTA, methyl paraben and its salts, capryloyl hydroxamic acid, sodium benzoate, benzyl alcohol, potassium sorbate, benzyl salicylate, methyl benzyl alcohol, Propylparaben, Methylchloroisothiazolinone, Methylisothiazolinone, Ethylhexylglycerin, Butylparaben, Ethylparaben, Sodium propylparaben, DMDM hydantoin, Dehydroacetic acid, Iodopropynyl butylcarbamate, Salicylic acid, Chlorphenesin, Isobutylparaben, Sodium ethylparaben, Diazolidinyl urea, Farnesol, Bisabolol, Sodium phytate or phytic acid, Sodium levulinate or levulinate Acid, Chlorhexidine, Glyceryl Laurate, Anisic Acid and Its Salts, Chlorhexidine Digluconate, TEA-Salicylate, Phenethyl Alcohol, Hexylene Glycol, Glyceryl Caprate, Sorbitan Caprylate, Tetrasodium Glutamate Diacetate, Trisodium Ethylenediamine Disuccinate, Hydroxyethoxyphenyl Butanone, Hydroxyethoxyphenyl Butanol, Itaconic Acid, Pyridone Ethanolamine Salt, Propylene Glycol Caprylate, Climbazole, Undecylenyl Glycine, Undecylenic Acid, Thymol, Glyceryl Caprylate Esters, 4-hydroxyacetophenone, sodium lactate, trisodium dicarboxymethyl alanine, 1,3-propylene glycol, 1,2-pentanediol, 1,2-hexanediol, 1,2-heptanediol, 1,2-octanediol, 1,2-nonanediol, 1,2-decanediol, 2,3-pentanediol, 2,3-hexanediol, 2,3-heptanediol, 2,3-octanediol, 2,3-nonanediol, 2,3-decanediol, and mixtures of two or more of the foregoing antimicrobial agents.
[0089] As used in this application, the phrase "at least one antimicrobial substance" means that the composition can include one antimicrobial agent, i.e. as a single compound, or can include more than one antimicrobial agent, i.e. in combination with one or more other antimicrobial compounds, i.e. two, three, four or more different antimicrobials as described herein. In order to enhance the antimicrobial effect and cover a wider range of antimicrobial effects, it is preferred to use a combination of two or more antimicrobial compounds.
[0090] In a preferred variant, the antimicrobial agent of the composition of the invention is chosen from o-cymene-5-ol, phenoxyethanol, disodium EDTA, methylparaben and its salts, caprylhydroxamic acid, sodium benzoate, benzyl alcohol, potassium sorbate, benzyl salicylate, methylbenzyl alcohol, propylparaben, methylchloroisothiazolinone, methylisothiazolinone, ethylhexylglycerol, butylparaben, ethylparaben, sodium propylparaben, DMDM hydantoin, dehydroacetic acid, iodopropynyl butylcarbamate, salicylic acid, chlorphenesin, isobutylparaben, sodium ethylparaben, diazolidinyl urea, farnesol, bisabolol, sodium phytate or phytic acid, sodium levulinate or levulinic acid, chlorhexidine, glyceryl laurate, anisic acid and its salts , chlorhexidine digluconate, TEA-salicylate, phenethyl alcohol, hexylene glycol, glyceryl caprate, sorbitan caprylate, tetrasodium glutamate diacetate, trisodium ethylenediamine disuccinate, hydroxyethoxyphenyl butanone, hydroxyethoxyphenyl butanol, itaconic acid, pyridone ethanolamine salt, propylene glycol caprylate, climbazole, undecylenic acid, glyceryl caprylate, 4-hydroxyacetophenone, sodium lactate, 1,3-propylene glycol, 1,2-pentanediol, 1,2-hexanediol, 1,2-heptanediol, 1,2-octanediol, 1,2-nonanediol, 1,2-decanediol, 2,3-pentanediol, 2,3-hexanediol, 2,3-heptanediol, 2,3-octanediol, 2,3-nonanediol, 2,3-decanediol, and mixtures of two or more of the foregoing antimicrobial components.
[0091] In a particularly preferred variant, the microbiologically active agent of the composition of the invention is selected from o-cymene-5-ol, phenoxyethanol, disodium EDTA, methyl parahydroxybenzoate and its salts, caprylhydroxamic acid, sodium benzoate, benzyl alcohol, potassium sorbate, benzyl salicylate, methylbenzyl alcohol, propyl parahydroxybenzoate, methylchloroisothiazolinone, methylisothiazolinone, ethylhexylglycerol, butyl parahydroxybenzoate, ethyl parahydroxybenzoate, sodium propyl parahydroxybenzoate, DMDM hydantoin, hexylene glycol, hydroxyethoxyphenyl butanone, hydroxy Ethoxyphenyl butanol, itaconic acid, pyridone ethanolamine salt, propylene glycol caprylate, climbazole, undecylenic acid, glyceryl caprylate, 4-hydroxyacetophenone, 1,3-propylene glycol, 1,2-pentanediol, 1,2-hexanediol, 1,2-heptanediol, 1,2-octanediol, 1,2-nonanediol, 1,2-decanediol, 2,3-pentanediol, 2,3-hexanediol, 2,3-heptanediol, 2,3-octanediol, 2,3-nonanediol, 2,3-decanediol and mixtures of two or more of the foregoing antimicrobial components.
[0092] Component (b) according to the first aspect of the present invention is an alkyl ketal ester compound represented by the general formula (I) or a derivative thereof,
[0093]
[0094] in
[0095] R 1 is an optionally substituted C1 to C12 alkyl group or an optionally substituted C1 to C12 alkenyl group;
[0096] R 2 is hydrogen, optionally substituted C1 to C3 alkyl or optionally substituted C1 to C3 alkenyl;
[0097] R 3 , R 4 , R 5 , R 6 and R 7 are each independently hydrogen, optionally substituted C1 to C6 alkyl, or optionally substituted C1 to C6 alkenyl;
[0098] a is 0 or an integer from 1 to 6;
[0099] b is 0 or 1.
[0100] Some of the compounds within the scope of general formula (I) contain one or more chiral carbon atoms. The structure of general formula (I) does not distinguish between those possible stereoisomers, and is intended to include all such stereoisomers.
[0101] In a preferred variant, R 1 It is an optionally substituted C1 to C6 alkyl group, more preferably an optionally substituted C1 to C4 alkyl group, and most preferably an optionally substituted C1 or C2 alkyl group.
[0102] In a further preferred variant of the general formula (I), R 2 is hydrogen or C1 alkyl, more preferably R 2 It is a C1 alkyl group.
[0103] In a further preferred variant of the general formula (I), R 3 , R 4 , R 5 , R 6 and R 7 Each is independently hydrogen or optionally substituted C1 to C3 alkyl, more preferably optionally substituted C1 alkyl.
[0104] In further preferred variants of the general formula (I), a is an integer from 1 to 6, more particularly an integer from 1 to 4, still more preferably an integer of 2 or 3.
[0105] In still more preferred variants of general formula (I), R 1 is a C1 to C4 alkyl group, R 2 is methyl, R 3 , R 4 and R 5 are each independently hydrogen or C1 to C3 alkyl, R6 is hydrogen or C1 to C3 alkyl, R 7 is hydrogen or optionally substituted C1 to C3 alkyl, a is an integer from 2 to 3, and b is 0 or 1.
[0106] In still more preferred variants of general formula (I), R 1 is a C1 to C4 alkyl group, R 2 is methyl, R 3 , R 4 and R 5 are independently hydrogen, R 5 is hydrogen, R 6 is hydrogen or C1 to C3 alkyl, R 7 is hydrogen or optionally substituted C1 to C3 alkyl, a is an integer of 2, and b is 0 or 1.
[0107] In still more preferred variants of general formula (I), R 1 is a C1 to C4 alkyl group, R 2 is methyl, R 3 , R 4 and R 5 are independently hydrogen, R 5 is hydrogen, R 6 is hydrogen, R 7 is hydrogen, a is the integer 2, and b is 0 or 1.
[0108] In still more preferred variations, the alkyl ketal esters include those having the following structures (II) to (VII):
[0109]
[0110] Where R 1 is methyl, ethyl, n-propyl or n-butyl;
[0111]
[0112] Where R 1 is methyl, ethyl, n-propyl or n-butyl;
[0113]
[0114] Where R 1 is methyl, ethyl, n-propyl or n-butyl;
[0115]
[0116] Where R 1 is methyl, ethyl, n-propyl or n-butyl;
[0117]
[0118] Where R 1 is methyl, ethyl, n-propyl or n-butyl; and R 3 is methyl or ethyl; and
[0119]
[0120] Where R 1 It is methyl, ethyl, n-propyl or n-butyl.
[0121] In a most preferred variant according to the first aspect of the present invention, the alkyl ketal ester is selected from ethyl levulinate propylene glycol acetal
[0122]
[0123] Ethyl levulinate glycerol acetal
[0124]
[0125] 3-(2,4-Dimethyl-1,3-dioxolan-2-yl)butyl propionate
[0126]
[0127] and mixtures thereof.
[0128] Alkyl ketal ester compounds of the known general formula (I) are excellent formulation ingredients that provide a number of benefits. The alkyl ketal ester compounds are excellent solvents for a wide range of materials, including active agents that can be used in personal care formulations. Many of them are at least partially miscible with water or other organic solvents, or both, that are typically present in, for example, personal care formulations, as well as a wide range of slightly hydrophobic materials. The alkyl ester compounds have low volatility. Under conventional manufacturing, storage and use conditions, the alkyl ketal esters do not react with many other materials that are typically found in, for example, personal care formulations. In addition, the alkyl ketal esters can act as emulsifiers or compatibilizers.
[0129] The alkyl ketal ester compounds as defined herein can be obtained by acid-catalyzed reaction of the corresponding ketoesters with diols, or by transesterification of ketal esters, as described, for example, in US 2014 / 0147395 A1.
[0130] It was surprisingly found that the alkyl ketal ester compounds according to general formula (I) as defined herein achieve a synergistic antimicrobial effect against bacteria, yeasts and fungi / molds when combined with an antimicrobial agent as defined herein, as shown in the following examples.
[0131] In a preferred advantageous variant, the composition according to the first or second aspect of the invention comprises one of the following combinations of components (a) and (b):
[0132] - o-cymene-5-ol and an alkyl ketal ester compound according to formula (I),
[0133] - isopropyl p-hydroxybenzoate and an alkyl ketal ester compound according to formula (I);
[0134] - capryloylglycine and an alkyl ketal ester compound according to formula (I);
[0135] - phenylpropanol and an alkyl ketal ester compound according to formula (I);
[0136] - tropolone and an alkyl ketal ester compound according to formula (I);
[0137] - PCA cocoyl arginine ethyl ester salt and an alkyl ketal ester compound according to formula (I);
[0138] -2-methyl-5-cyclohexylpentanol and an alkyl ketal ester compound according to formula (I);
[0139] - phenoxyethanol and an alkyl ketal ester compound according to formula (I);
[0140] - disodium EDTA and an alkyl ketal ester compound according to formula (I);
[0141] - methyl p-hydroxybenzoate or a salt thereof and an alkyl ketal ester compound according to formula (I);
[0142] - octanoylhydroxamic acid and an alkyl ketal ester compound according to formula (I);
[0143] - sodium benzoate and an alkyl ketal ester compound according to formula (I);
[0144] - benzyl alcohol and an alkyl ketal ester compound according to formula (I);
[0145] - potassium sorbate and an alkyl ketal ester compound according to formula (I);
[0146] - benzyl salicylate and an alkyl ketal ester compound according to formula (I);
[0147] - methylbenzyl alcohol and an alkyl ketal ester compound according to formula (I);
[0148] - propyl paraben and an alkyl ketal ester compound according to formula (I);
[0149] - methylchloroisothiazolinone and an alkyl ketal ester compound according to formula (I);
[0150] - methylisothiazolinone and an alkyl ketal ester compound according to formula (I);
[0151] - ethylhexylglycerol and an alkyl ketal ester compound according to formula (I);
[0152] - butyl p-hydroxybenzoate and an alkyl ketal ester compound according to formula (I);
[0153] - ethyl p-hydroxybenzoate and an alkyl ketal ester compound according to formula (I);
[0154] - sodium propyl paraben and an alkyl ketal ester compound according to formula (I);
[0155] -DMDM hydantoin and an alkyl ketal ester compound according to formula (I);
[0156] - dehydroacetic acid and an alkyl ketal ester compound according to formula (I);
[0157] - iodopropynyl butylcarbamate and an alkyl ketal ester compound according to formula (I); - salicylic acid and an alkyl ketal ester compound according to formula (I);
[0158] - chlorophenicol ether and an alkyl ketal ester compound according to formula (I);
[0159] - isobutyl p-hydroxybenzoate and an alkyl ketal ester compound according to formula (I);
[0160] - sodium ethyl p-hydroxybenzoate and an alkyl ketal ester compound according to formula (I);
[0161] - diazolidinyl urea and an alkyl ketal ester compound according to formula (I);
[0162] - farnesol and an alkyl ketal ester compound according to formula (I);
[0163] - bisabolol and an alkyl ketal ester compound according to formula (I);
[0164] - sodium phytate or phytic acid and an alkyl ketal ester compound according to formula (I);
[0165] - sodium levulinate or levulinic acid and an alkyl ketal ester compound according to formula (I); - chlorhexidine and an alkyl ketal ester compound according to formula (I);
[0166] - glyceryl laurate and an alkyl ketal ester compound according to formula (I);
[0167] - anisic acid or a salt thereof and an alkyl ketal ester compound according to formula (I);
[0168] - chlorhexidine digluconate and an alkyl ketal ester compound according to formula (I);
[0169] -TEA-salicylate and an alkyl ketal ester compound according to formula (I);
[0170] - phenylethanol and an alkyl ketal ester compound according to formula (I);
[0171] - hexanediol and an alkyl ketal ester compound according to formula (I);
[0172] - glyceryl caprate and an alkyl ketal ester compound according to formula (I);
[0173] - sorbitan caprylate and an alkyl ketal ester compound according to formula (I);
[0174] - tetrasodium glutamate diacetate and an alkyl ketal ester compound according to formula (I);
[0175] - trisodium ethylenediamine disuccinate and an alkyl ketal ester compound according to formula (I);
[0176] - hydroxyethoxyphenyl butanone and an alkyl ketal ester compound according to formula (I);
[0177] - hydroxyethoxyphenylbutanol and an alkyl ketal ester compound according to formula (I);
[0178] - itaconic acid and an alkyl ketal ester compound according to formula (I);
[0179] - a pyridone ethanolamine salt and an alkyl ketal ester compound according to formula (I);
[0180] - propylene glycol caprylate and an alkyl ketal ester compound according to formula (I);
[0181] - climbazole and an alkyl ketal ester compound according to formula (I);
[0182] - undecylenoylglycine and an alkyl ketal ester compound according to formula (I);
[0183] - undecylenic acid and an alkyl ketal ester compound according to formula (I);
[0184] - thymol and an alkyl ketal ester compound according to formula (I);
[0185] - glyceryl caprylate and an alkyl ketal ester compound according to formula (I);
[0186] -4-hydroxyacetophenone and an alkyl ketal ester compound according to formula (I);
[0187] - sodium lactate and an alkyl ketal ester compound according to formula (I);
[0188] - trisodium dicarboxymethylalaninate and an alkyl ketal ester compound according to formula (I);
[0189] -1,3-propanediol and an alkyl ketal ester compound according to formula (I);
[0190] -1,2-pentanediol and an alkyl ketal ester compound according to formula (I);
[0191] -1,2-hexanediol and an alkyl ketal ester compound according to formula (I);
[0192] -1,2-heptanediol and an alkyl ketal ester compound according to formula (I);
[0193] -1,2-octanediol and an alkyl ketal ester compound according to formula (I);
[0194] -1,2-nonanediol and an alkyl ketal ester compound according to formula (I);
[0195] -1,2-decanediol and an alkyl ketal ester compound according to formula (I);
[0196] -2,3-pentanediol and an alkyl ketal ester compound according to formula (I);
[0197] -2,3-hexanediol and an alkyl ketal ester compound according to formula (I);
[0198] -2,3-heptanediol and an alkyl ketal ester compound according to formula (I);
[0199] -2,3-octanediol and an alkyl ketal ester compound according to formula (I);
[0200] -2,3-nonanediol and an alkyl ketal ester compound according to formula (I);
[0201] -2,3-decanediol and an alkyl ketal ester compound according to formula (I); or
[0202] - A mixture of two or more of the aforementioned antimicrobial agents and an alkyl ketal ester compound according to formula (I).
[0203] The combination of the above-specified antimicrobial agents and the alkyl ketal ester compounds according to formula (I) exhibits a synergistic antimicrobial effect against a broad spectrum of microorganisms (i.e., against bacteria, yeasts, and fungi / molds) compared to their respective single antimicrobial agents, as demonstrated by the MIC (minimum inhibitory concentration) test in the following examples.
[0204] In a more preferred advantageous variant, the composition according to the first or second aspect of the invention comprises one of the following combinations of components (a) and (b):
[0205] - o-cymene-5-ol and ethyl levulinate propylene glycol acetal;
[0206] - o-Cymene-5-ol and ethyl levulinate glycerol acetal;
[0207] - o-cymene-5-ol and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate;
[0208] - isopropyl paraben and ethyl levulinate propylene glycol acetal;
[0209] - isopropyl p-hydroxybenzoate and ethyl levulinate glyceryl acetal;
[0210] - isopropyl p-hydroxybenzoate and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl)propionate;
[0211] - Capryloylglycine and ethyl levulinate propylene glycol acetal;
[0212] - Capryloylglycine and ethyl levulinate glycerol acetal;
[0213] -octanoylglycine and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate;
[0214] -phenylpropanol and ethyl levulinate propylene glycol acetal;
[0215] -phenylpropanol and ethyl levulinate glycerol acetal;
[0216] -phenylpropanol and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate;
[0217] -tropolone and ethyl levulinate propylene glycol acetal;
[0218] -tropolone and ethyl levulinate glycerol acetal;
[0219] - tropolone and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate;
[0220] - PCA ethyl cocoyl arginate and propylene glycol ethyl levulinate acetal;
[0221] - PCA ethyl cocoyl arginate and ethyl levulinate glyceryl acetal;
[0222] - PCA cocoyl arginine ethyl ester and 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionic acid butyl ester;
[0223] -2-Methyl-5-cyclohexylpentanol and ethyl levulinate propylene glycol acetal:
[0224] -2-methyl-5-cyclohexylpentanol and ethyl levulinate glycerol acetal;
[0225] -2-methyl-5-cyclohexylpentanol and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate;
[0226] - phenoxyethanol and ethyl levulinate propylene glycol acetal;
[0227] - phenoxyethanol and ethyl levulinate glyceryl acetal;
[0228] - phenoxyethanol and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate;
[0229] -Disodium EDTA and ethyl levulinate propylene glycol acetal;
[0230] - Disodium EDTA and ethyl levulinate glyceryl acetal;
[0231] - Disodium EDTA and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate;
[0232] - methyl p-hydroxybenzoate or its salts and ethyl levulinate propylene glycol acetal;
[0233] - methyl p-hydroxybenzoate or its salts and ethyl levulinate glycerol acetal;
[0234] - methyl p-hydroxybenzoate or its salt and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl)propionate; - octanoylhydroxamic acid and ethyl levulinate propylene glycol acetal;
[0235] - Caprylhydroxamic acid and ethyl levulinate glycerol acetal;
[0236] -octanoylhydroxamic acid and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate;
[0237] - sodium benzoate and ethyl levulinate propylene glycol acetal;
[0238] - sodium benzoate and ethyl levulinate glycerol acetal;
[0239] - sodium benzoate and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl)propionate;
[0240] -benzyl alcohol and ethyl levulinate propylene glycol acetal;
[0241] -benzyl alcohol and ethyl levulinate glycerol acetal;
[0242] -benzyl alcohol and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate;
[0243] - Potassium sorbate and ethyl levulinate propylene glycol acetal;
[0244] - Potassium sorbate and ethyl levulinate glycerol acetal;
[0245] - Potassium sorbate and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl)propionate;
[0246] - benzyl salicylate and ethyl levulinate propylene glycol acetal;
[0247] - benzyl salicylate and ethyl levulinate glycerol acetal;
[0248] - benzyl salicylate and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl)propionate;
[0249] -methylbenzyl alcohol and ethyl levulinate propylene glycol acetal;
[0250] -methylbenzyl alcohol and ethyl levulinate glycerol acetal;
[0251] -methylbenzyl alcohol and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate;
[0252] -propylparaben and ethyllevulinate propylene glycol acetal;
[0253] - Propylparaben and ethyllevulinate glyceryl acetal;
[0254] -propyl p-hydroxybenzoate and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl)propionate; -methylchloroisothiazolinone and ethyl levulinate propylene glycol acetal;
[0255] -Methylchloroisothiazolinone and ethyl levulinate glycerol acetal;
[0256] -Methylchloroisothiazolinone and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl)propionate; -Methylisothiazolinone and ethyl levulinate propylene glycol acetal;
[0257] -Methylisothiazolinone and ethyl levulinate glycerol acetal;
[0258] -methylisothiazolinone and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl)propionate; -ethylhexylglycerol and ethyl levulinate propylene glycol acetal;
[0259] - ethylhexylglycerol and ethyl levulinate glyceryl acetal;
[0260] - ethylhexylglycerol and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl)propionate;
[0261] -butyl paraben and ethyl levulinate propylene glycol acetal;
[0262] -Butyl p-hydroxybenzoate and ethyl levulinate glyceryl acetal;
[0263] - butyl p-hydroxybenzoate and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl)propionate;
[0264] - ethyl p-hydroxybenzoate and ethyl levulinate propylene glycol acetal;
[0265] - ethyl p-hydroxybenzoate and ethyl levulinate glyceryl acetal;
[0266] - ethyl p-hydroxybenzoate and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl)propionate;
[0267] - sodium propyl paraben and propylene glycol ethyl levulinate acetal;
[0268] - sodium propyl paraben and ethyl levulinate glyceryl acetal;
[0269] - sodium propyl p-hydroxybenzoate and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl)propionate;
[0270] -DMDM hydantoin and ethyl levulinate propylene glycol acetal;
[0271] -DMDM hydantoin and ethyl levulinate glycerol acetal;
[0272] -DMDM hydantoin and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate;
[0273] -dehydroacetic acid and ethyl levulinate propylene glycol acetal;
[0274] - dehydroacetic acid and ethyl levulinate glycerol acetal;
[0275] - dehydroacetic acid and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl)propionate;
[0276] -Iodopropynyl butylcarbamate and ethyl levulinate propylene glycol acetal;
[0277] -Iodopropynyl butylcarbamate and ethyl levulinate glycerol acetal;
[0278] -butyl iodopropynyl carbamate and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate;
[0279] - salicylic acid and ethyl levulinate propylene glycol acetal;
[0280] - Salicylic acid and ethyl levulinate glycerol acetal;
[0281] - salicylic acid and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl)propionate;
[0282] -Chlorophenone glyceryl ether and ethyl levulinate propylene glycol acetal;
[0283] - Chlorophenone glyceryl ether and ethyl levulinate glyceryl acetal;
[0284] -Chlorophenicyl ether and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate;
[0285] - isobutyl paraben and ethyl levulinate propylene glycol acetal;
[0286] - isobutyl p-hydroxybenzoate and ethyl levulinate glyceryl acetal;
[0287] - isobutyl p-hydroxybenzoate and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl) propionate; - sodium ethyl p-hydroxybenzoate and ethyl levulinate propylene glycol acetal;
[0288] - Sodium ethyl paraben and ethyl levulinate glyceryl acetal;
[0289] - sodium ethyl p-hydroxybenzoate and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl)propionate; - diazolidinyl urea and ethyl levulinate propylene glycol acetal;
[0290] -diazolidinyl urea and ethyl levulinate glycerol acetal;
[0291] -diazolidinyl urea and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate;
[0292] - farnesol and ethyl levulinate propylene glycol acetal;
[0293] - Farnesol and ethyl levulinate glycerol acetal;
[0294] -farnesol and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate;
[0295] - Bisabolol and ethyl levulinate propylene glycol acetal;
[0296] -Bisabolol and ethyl levulinate glyceryl acetal;
[0297] - Bisabolol and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl) propionate;
[0298] - sodium phytate or phytic acid and ethyl levulinate propylene glycol acetal;
[0299] - sodium phytate or phytic acid and ethyl levulinate glycerol acetal;
[0300] - sodium phytate or phytic acid and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl)propionate;
[0301] - sodium levulinate or levulinic acid and ethyl levulinate propylene glycol acetal;
[0302] - sodium levulinate or levulinic acid and ethyl levulinate glycerol acetal;
[0303] - sodium levulinate or levulinic acid and 3-(2,4-dimethyl-1,3-dioxolan-2-yl)butyl propionate; - chlorhexidine and ethyl levulinate propylene glycol acetal;
[0304] -Chlorhexidine and ethyl levulinate glycerol acetal;
[0305] -Chlorhexidine and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl)propionate;
[0306] - Glyceryl laurate and ethyl levulinate propylene glycol acetal;
[0307] - Glyceryl laurate and ethyl levulinate glyceryl acetal;
[0308] - glyceryl laurate and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl) propionate;
[0309] - anisic acid or its salts and ethyl levulinate propylene glycol acetal;
[0310] - anisic acid or its salts and ethyl levulinate glycerol acetal;
[0311] - anisic acid or its salts and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate;
[0312] - chlorhexidine digluconate and ethyl levulinate propylene glycol acetal;
[0313] - Chlorhexidine digluconate and ethyl levulinate glycerol acetal;
[0314] -Chlorhexidine digluconate and 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionic acid butyl ester; -TEA-salicylate and ethyl levulinate propylene glycol acetal;
[0315] -TEA-salicylate and ethyl levulinate glycerol acetal;
[0316] -TEA-salicylate and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate;
[0317] - phenylethyl alcohol and ethyl levulinate propylene glycol acetal;
[0318] - phenylethyl alcohol and ethyl levulinate glycerol acetal;
[0319] -phenylethanol and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate;
[0320] - hexanediol and ethyl levulinate propylene glycol acetal;
[0321] - hexanediol and ethyl levulinate glycerol acetal;
[0322] -hexanediol and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate;
[0323] - Glyceryl caprate and ethyl levulinate propylene glycol acetal;
[0324] - Glyceryl caprate and ethyl levulinate glyceryl acetal;
[0325] - glyceryl caprate and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl) propionate;
[0326] - sorbitan octanoate and ethyl levulinate propylene glycol acetal;
[0327] - Sorbitan octanoate and ethyl levulinate glycerol acetal;
[0328] - sorbitan octanoate and 3-(2,4-dimethyl-1,3-dioxolan-2-yl)propionic acid butyl ester; - tetrasodium glutamate diacetate and ethyl levulinate propylene glycol acetal;
[0329] - Tetrasodium glutamate diacetate and ethyl levulinate glycerol acetal;
[0330] - Tetrasodium glutamate diacetate and 3-(2,4-dimethyl-1,3-dioxolan-2-yl)butyl propionate; - Trisodium ethylenediamine disuccinate and ethyl levulinate propylene glycol acetal;
[0331] - trisodium ethylenediamine disuccinate and ethyl levulinate glycerol acetal;
[0332] -Trisodium ethylenediamine disuccinate and 3-(2,4-dimethyl-1,3-dioxolan-2-yl)butyl propionate; -Hydroxyethoxyphenyl butanone and ethyl levulinate propylene glycol acetal;
[0333] -Hydroxyethoxyphenylbutanone and ethyl levulinate glycerol acetal;
[0334] -Hydroxyethoxyphenyl butanone and 3-(2,4-dimethyl-1,3-dioxolan-2-yl)butyl propionate; -Hydroxyethoxyphenyl butanol and ethyl levulinate propylene glycol acetal;
[0335] -Hydroxyethoxyphenylbutanol and ethyl levulinate glycerol acetal;
[0336] -Hydroxyethoxyphenylbutanol and 3-(2,4-dimethyl-1,3-dioxolan-2-yl)propionic acid butyl ester; -itaconic acid and ethyl levulinate propylene glycol acetal;
[0337] - itaconic acid and ethyl levulinate glycerol acetal;
[0338] - itaconic acid and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl)propionate;
[0339] - pyridone ethanolamine salt and ethyl levulinate propylene glycol acetal;
[0340] - pyridone ethanolamine salt and ethyl levulinate glycerol acetal;
[0341] -Pyridone ethanolamine salt and 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionic acid butyl ester;
[0342] -propylene glycol octanoate and propylene glycol ethyl levulinate acetal;
[0343] - Propylene glycol caprylate and ethyl levulinate glyceryl acetal;
[0344] -propylene glycol octanoate and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate;
[0345] - Climbazole and ethyl levulinate propylene glycol acetal;
[0346] - Climbazole and ethyl levulinate glycerol acetal;
[0347] -Climbazole and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate;
[0348] - undecylenoylglycine and ethyl levulinate propylene glycol acetal;
[0349] - Undecylenoylglycine and ethyl levulinate glycerol acetal;
[0350] - Undecenoylglycine and 3-(2,4-dimethyl-1,3-dioxolan-2-yl)propionic acid butyl ester; - Undecenoic acid and ethyl levulinate propylene glycol acetal;
[0351] - Undecylenic acid and ethyl levulinate glycerol acetal;
[0352] -Undecenoic acid and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate;
[0353] -thymol and ethyl levulinate propylene glycol acetal;
[0354] -thymol and ethyl levulinate glycerol acetal;
[0355] - thymol and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl)propionate;
[0356] - Glyceryl caprylate and propylene glycol ethyl levulinate acetal;
[0357] - Glyceryl caprylate and ethyl levulinate glyceryl acetal;
[0358] - Glyceryl caprylate and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl) propionate;
[0359] -4-hydroxyacetophenone and ethyl levulinate propylene glycol acetal;
[0360] -4-hydroxyacetophenone and ethyl levulinate glycerol acetal;
[0361] -4-hydroxyacetophenone and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate;
[0362] - sodium lactate and ethyl levulinate propylene glycol acetal;
[0363] - sodium lactate and ethyl levulinate glycerol acetal;
[0364] - sodium lactate and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl)propionate;
[0365] - trisodium dicarboxymethylalaninate and propylene glycol ethyl levulinate acetal;
[0366] - trisodium dicarboxymethylalanine and ethyl levulinate glycerol acetal;
[0367] - trisodium dicarboxymethyl alanine and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl) propionate; - 1,3-propanediol and ethyl levulinate propylene glycol acetal;
[0368] -1,3-Propanediol and ethyl levulinate glycerol acetal;
[0369] -1,3-propanediol and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate;
[0370] -1,2-Pentanediol and Ethyl Levulinate Propylene Glycol Acetal:
[0371] -1,2-pentanediol and ethyl levulinate glycerol acetal;
[0372] -1,2-pentanediol and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate;
[0373] -1,2-Hexanediol and ethyl levulinate propylene glycol acetal;
[0374] -1,2-Hexanediol and ethyl levulinate glycerol acetal;
[0375] -1,2-hexanediol and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate;
[0376] -1,2-heptanediol and ethyl levulinate propylene glycol acetal;
[0377] -1,2-heptanediol and ethyl levulinate glycerol acetal;
[0378] -1,2-heptanediol and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate;
[0379] -1,2-octanediol and ethyl levulinate propylene glycol acetal;
[0380] -1,2-octanediol and ethyl levulinate glycerol acetal;
[0381] -1,2-octanediol and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate;
[0382] -1,2-nonanediol and ethyl levulinate propylene glycol acetal;
[0383] -1,2-nonanediol and ethyl levulinate glycerol acetal;
[0384] -1,2-nonanediol and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate;
[0385] -1,2-Decanediol and ethyl levulinate propylene glycol acetal;
[0386] -1,2-Decanediol and ethyl levulinate glycerol acetal;
[0387] -1,2-decanediol and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate;
[0388] -2,3-Pentanediol and ethyl levulinate propylene glycol acetal;
[0389] -2,3-pentanediol and ethyl levulinate glycerol acetal;
[0390] -2,3-pentanediol and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate;
[0391] -2,3-Hexanediol and ethyl levulinate propylene glycol acetal;
[0392] -2,3-Hexanediol and ethyl levulinate glycerol acetal;
[0393] -2,3-hexanediol and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate;
[0394] -2,3-heptanediol and ethyl levulinate propylene glycol acetal;
[0395] -2,3-heptanediol and ethyl levulinate glycerol acetal;
[0396] -2,3-heptanediol and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate;
[0397] -2,3-octanediol and ethyl levulinate propylene glycol acetal;
[0398] -2,3-octanediol and ethyl levulinate glycerol acetal;
[0399] -2,3-octanediol and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate;
[0400] -2,3-nonanediol and ethyl levulinate propylene glycol acetal;
[0401] -2,3-nonanediol and ethyl levulinate glycerol acetal;
[0402] -2,3-nonanediol and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate;
[0403] -2,3-Decanediol and ethyl levulinate propylene glycol acetal;
[0404] -2,3-Decanediol and ethyl levulinate glycerol acetal;
[0405] -2,3-decanediol and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate;
[0406] - a mixture of two or more of the foregoing antimicrobial agents and ethyl levulinate propylene glycol acetal;
[0407] - a mixture of two or more of the foregoing antimicrobial agents and ethyl levulinate glycerol acetal; or
[0408] - A mixture of two or more of the foregoing antimicrobial agents and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate.
[0409] Still more preferably the combination of components (a) and (b) in the composition according to the first aspect of the invention is:
[0410] - o-cymene-5-ol and ethyl levulinate propylene glycol acetal;
[0411] - o-Cymene-5-ol and ethyl levulinate glycerol acetal;
[0412] - o-cymene-5-ol and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate;
[0413] - phenoxyethanol and ethyl levulinate propylene glycol acetal;
[0414] - phenoxyethanol and ethyl levulinate glyceryl acetal;
[0415] - phenoxyethanol and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate;
[0416] -Disodium EDTA and ethyl levulinate propylene glycol acetal;
[0417] - Disodium EDTA and ethyl levulinate glyceryl acetal;
[0418] - Disodium EDTA and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate;
[0419] - methyl p-hydroxybenzoate or its salts and ethyl levulinate propylene glycol acetal;
[0420] - methylparaben and ethyllevulinate glycerol acetal;
[0421] - methyl p-hydroxybenzoate and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl)propionate;
[0422] - Caprylhydroxamic acid and ethyl levulinate propylene glycol acetal;
[0423] - Caprylhydroxamic acid and ethyl levulinate glycerol acetal;
[0424] -octanoylhydroxamic acid and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate;
[0425] - sodium benzoate and ethyl levulinate propylene glycol acetal;
[0426] - sodium benzoate and ethyl levulinate glycerol acetal;
[0427] - sodium benzoate and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl)propionate;
[0428] -benzyl alcohol and ethyl levulinate propylene glycol acetal;
[0429] -benzyl alcohol and ethyl levulinate glycerol acetal;
[0430] -benzyl alcohol and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate;
[0431] - Potassium sorbate and ethyl levulinate propylene glycol acetal;
[0432] - Potassium sorbate and ethyl levulinate glycerol acetal;
[0433] - Potassium sorbate and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl)propionate;
[0434] - benzyl salicylate and ethyl levulinate propylene glycol acetal;
[0435] - benzyl salicylate and ethyl levulinate glycerol acetal;
[0436] - benzyl salicylate and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl)propionate;
[0437] -methylbenzyl alcohol and ethyl levulinate propylene glycol acetal;
[0438] -methylbenzyl alcohol and ethyl levulinate glycerol acetal;
[0439] -methylbenzyl alcohol and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate;
[0440] -propylparaben and ethyllevulinate propylene glycol acetal;
[0441] - Propylparaben and ethyllevulinate glyceryl acetal;
[0442] -propyl p-hydroxybenzoate and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl)propionate; -methylchloroisothiazolinone and ethyl levulinate propylene glycol acetal;
[0443] -Methylchloroisothiazolinone and ethyl levulinate glycerol acetal;
[0444] -Methylchloroisothiazolinone and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl)propionate; -Methylisothiazolinone and ethyl levulinate propylene glycol acetal;
[0445] -Methylisothiazolinone and ethyl levulinate glycerol acetal;
[0446] -methylisothiazolinone and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate;
[0447] - ethylhexylglycerin and propylene glycol ethyl levulinate acetal;
[0448] - ethylhexylglycerol and ethyl levulinate glyceryl acetal;
[0449] - ethylhexylglycerol and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl)propionate;
[0450] -butyl paraben and ethyl levulinate propylene glycol acetal;
[0451] -Butyl p-hydroxybenzoate and ethyl levulinate glyceryl acetal;
[0452] - butyl p-hydroxybenzoate and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl)propionate; - ethyl p-hydroxybenzoate and ethyl levulinate propylene glycol acetal;
[0453] - ethyl p-hydroxybenzoate and ethyl levulinate glyceryl acetal;
[0454] - ethyl p-hydroxybenzoate and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl)propionate; - sodium propyl p-hydroxybenzoate and ethyl levulinate propylene glycol acetal;
[0455] - sodium propyl paraben and ethyl levulinate glyceryl acetal;
[0456] - sodium propyl paraben and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl) propionate; - DMDM hydantoin and ethyl levulinate propylene glycol acetal;
[0457] -DMDM hydantoin and ethyl levulinate glycerol acetal;
[0458] -DMDM hydantoin and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate;
[0459] - hexanediol and ethyl levulinate propylene glycol acetal;
[0460] - hexanediol and ethyl levulinate glycerol acetal;
[0461] -hexanediol and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate;
[0462] -Hydroxyethoxyphenyl butanone and ethyl levulinate propylene glycol acetal;
[0463] -Hydroxyethoxyphenylbutanone and ethyl levulinate glycerol acetal;
[0464] -Hydroxyethoxyphenyl butanone and 3-(2,4-dimethyl-1,3-dioxolan-2-yl)butyl propionate; -Hydroxyethoxyphenyl butanol and ethyl levulinate propylene glycol acetal;
[0465] -Hydroxyethoxyphenylbutanol and ethyl levulinate glycerol acetal;
[0466] -Hydroxyethoxyphenyl and 3-(2,4-dimethyl-1,3-dioxolan-2-yl)butyl propionate; -Itaconic acid and ethyl levulinate propylene glycol acetal;
[0467] - itaconic acid and ethyl levulinate glycerol acetal;
[0468] - itaconic acid and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl)propionate;
[0469] - pyridone ethanolamine salt and ethyl levulinate propylene glycol acetal;
[0470] - pyridone ethanolamine salt and ethyl levulinate glycerol acetal;
[0471] - pyridone ethanolamine salt and 3-(2,4-dimethyl-1,3-dioxolan-2-yl-) propionic acid butyl ester; - propylene glycol octanoate and ethyl levulinate propylene glycol acetal;
[0472] - Propylene glycol caprylate and ethyl levulinate glyceryl acetal;
[0473] -propylene glycol octanoate and 3-(2,4-dimethyl-1,3-dioxolan-2-yl)butyl propionate; -climbazole and ethyl levulinate propylene glycol acetal;
[0474] - Climbazole and ethyl levulinate glycerol acetal;
[0475] -Climbazole and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate;
[0476] - undecylenic acid and ethyl levulinate propylene glycol acetal;
[0477] - Undecylenic acid and ethyl levulinate glycerol acetal;
[0478] -Undecenoic acid and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate;
[0479] - Glyceryl caprylate and propylene glycol ethyl levulinate acetal;
[0480] - Glyceryl caprylate and ethyl levulinate glyceryl acetal;
[0481] - Glyceryl caprylate and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl) propionate;
[0482] -4-hydroxyacetophenone and ethyl levulinate propylene glycol acetal;
[0483] -4-hydroxyacetophenone and ethyl levulinate glycerol acetal;
[0484] -4-hydroxyacetophenone and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate;
[0485] -1,3-Propanediol and ethyl levulinate propylene glycol acetal;
[0486] -1,3-Propanediol and ethyl levulinate glycerol acetal;
[0487] -1,3-propanediol and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate;
[0488] -1,2-Pentanediol and ethyl levulinate propylene glycol acetal;
[0489] -1,2-pentanediol and ethyl levulinate glycerol acetal;
[0490] -1,2-pentanediol and 3-(2,4-dimethyl-1,3-dioxolan-2-yl)butyl propionate; -1,2-hexanediol and ethyl levulinate propylene glycol acetal;
[0491] -1,2-Hexanediol and ethyl levulinate glycerol acetal;
[0492] -1,2-Hexanediol and 3-(2,4-dimethyl-1,3-dioxolan-2-yl)butyl propionate; -1,2-Heptanediol and ethyl levulinate propylene glycol acetal;
[0493] -1,2-heptanediol and ethyl levulinate glycerol acetal;
[0494] -1,2-heptanediol and 3-(2,4-dimethyl-1,3-dioxolan-2-yl)propionic acid butyl ester; -1,2-octanediol and ethyl levulinate propylene glycol acetal;
[0495] -1,2-octanediol and ethyl levulinate glycerol acetal;
[0496] -1,2-octanediol and 3-(2,4-dimethyl-1,3-dioxolan-2-yl)propionic acid butyl ester; -1,2-nonanediol and ethyl levulinate propylene glycol acetal;
[0497] -1,2-nonanediol and ethyl levulinate glycerol acetal;
[0498] -1,2-nonanediol and 3-(2,4-dimethyl-1,3-dioxolan-2-yl)butyl propionate; -1,2-decanediol and ethyl levulinate propylene glycol acetal;
[0499] -1,2-Decanediol and ethyl levulinate glycerol acetal;
[0500] -1,2-decanediol and 3-(2,4-dimethyl-1,3-dioxolan-2-yl)butyl propionate; -2,3-pentanediol and ethyl levulinate propylene glycol acetal;
[0501] -2,3-pentanediol and ethyl levulinate glycerol acetal;
[0502] -2,3-pentanediol and 3-(2,4-dimethyl-1,3-dioxolan-2-yl)butyl propionate; -2,3-hexanediol and ethyl levulinate propylene glycol acetal;
[0503] -2,3-Hexanediol and ethyl levulinate glycerol acetal;
[0504] -2,3-Hexanediol and 3-(2,4-dimethyl-1,3-dioxolan-2-yl)butyl propionate; -2,3-Octanediol and ethyl levulinate propylene glycol acetal;
[0505] -2,3-octanediol and ethyl levulinate glycerol acetal;
[0506] -2,3-octanediol and 3-(2,4-dimethyl-1,3-dioxolan-2-yl)propionic acid butyl ester; -2,3-nonanediol and ethyl levulinate propylene glycol acetal;
[0507] -2,3-nonanediol and ethyl levulinate glycerol acetal;
[0508] -2,3-nonanediol and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate;
[0509] -2,3-Decanediol and ethyl levulinate propylene glycol acetal;
[0510] -2,3-Decanediol and ethyl levulinate glycerol acetal;
[0511] -2,3-decanediol and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate;
[0512] - a mixture of two or more of the foregoing antimicrobial agents and ethyl levulinate propylene glycol acetal;
[0513] - a mixture of two or more of the foregoing antimicrobial agents and ethyl levulinate glycerol acetal; or
[0514] - A mixture of two or more of the foregoing antimicrobial agents and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate.
[0515] The most preferred combination of components (a) and (b) in the composition according to the first aspect of the present invention is:
[0516] - o-cymene-5-ol and ethyl levulinate propylene glycol acetal;
[0517] - o-Cymene-5-ol and ethyl levulinate glycerol acetal;
[0518] - o-cymene-5-ol and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate;
[0519] - ethylhexylglycerin and propylene glycol ethyl levulinate acetal;
[0520] - ethylhexylglycerol and ethyl levulinate glyceryl acetal;
[0521] - ethylhexylglycerol and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl)propionate;
[0522] - Glyceryl caprylate and propylene glycol ethyl levulinate acetal;
[0523] - Glyceryl caprylate and ethyl levulinate glyceryl acetal;
[0524] - Glyceryl caprylate and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl) propionate;
[0525] -4-hydroxyacetophenone and ethyl levulinate propylene glycol acetal;
[0526] -4-hydroxyacetophenone and ethyl levulinate glycerol acetal;
[0527] -4-hydroxyacetophenone and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate;
[0528] -1,3-Propanediol and ethyl levulinate propylene glycol acetal;
[0529] -1,3-Propanediol and ethyl levulinate glycerol acetal;
[0530] -1,3-propanediol and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate;
[0531] -1,2-Pentanediol and ethyl levulinate propylene glycol acetal;
[0532] -1,2-pentanediol and ethyl levulinate glycerol acetal;
[0533] -1,2-pentanediol and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate;
[0534] -1,2-Hexanediol and ethyl levulinate propylene glycol acetal;
[0535] -1,2-Hexanediol and ethyl levulinate glycerol acetal;
[0536] -1,2-Hexanediol and 3-(2,4-dimethyl-1,3-dioxolan-2-yl)butyl propionate; -1,2-Heptanediol and ethyl levulinate propylene glycol acetal;
[0537] -1,2-heptanediol and ethyl levulinate glycerol acetal;
[0538] -1,2-heptanediol and 3-(2,4-dimethyl-1,3-dioxolan-2-yl)propionic acid butyl ester; -1,2-octanediol and ethyl levulinate propylene glycol acetal;
[0539] -1,2-octanediol and ethyl levulinate glycerol acetal;
[0540] -1,2-octanediol and 3-(2,4-dimethyl-1,3-dioxolan-2-yl)propionic acid butyl ester; -1,2-nonanediol and ethyl levulinate propylene glycol acetal;
[0541] -1,2-nonanediol and ethyl levulinate glycerol acetal;
[0542] -1,2-nonanediol and 3-(2,4-dimethyl-1,3-dioxolan-2-yl)butyl propionate; -1,2-decanediol and ethyl levulinate propylene glycol acetal;
[0543] -1,2-Decanediol and ethyl levulinate glycerol acetal;
[0544] -1,2-decanediol and 3-(2,4-dimethyl-1,3-dioxolan-2-yl)butyl propionate; -2,3-pentanediol and ethyl levulinate propylene glycol acetal;
[0545] -2,3-pentanediol and ethyl levulinate glycerol acetal;
[0546] -2,3-pentanediol and 3-(2,4-dimethyl-1,3-dioxolan-2-yl)butyl propionate; -2,3-hexanediol and ethyl levulinate propylene glycol acetal;
[0547] -2,3-Hexanediol and ethyl levulinate glycerol acetal;
[0548] -2,3-Hexanediol and 3-(2,4-dimethyl-1,3-dioxolan-2-yl)butyl propionate; -2,3-Octanediol and ethyl levulinate propylene glycol acetal;
[0549] -2,3-octanediol and ethyl levulinate glycerol acetal;
[0550] -2,3-octanediol and 3-(2,4-dimethyl-1,3-dioxolan-2-yl)propionic acid butyl ester; -2,3-nonanediol and ethyl levulinate propylene glycol acetal;
[0551] -2,3-nonanediol and ethyl levulinate glycerol acetal;
[0552] -2,3-nonanediol and 3-(2,4-dimethyl-1,3-dioxolan-2-yl)butyl propionate; -2,3-decanediol and ethyl levulinate propylene glycol acetal;
[0553] -2,3-Decanediol and ethyl levulinate glycerol acetal;
[0554] -2,3-decanediol and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate;
[0555] - a mixture of two or more of the foregoing antimicrobial agents and ethyl levulinate propylene glycol acetal;
[0556] - a mixture of two or more of the foregoing antimicrobial agents and ethyl levulinate glycerol acetal; or
[0557] - A mixture of two or more of the foregoing antimicrobial agents and butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate.
[0558] In the above defined antimicrobial substance / alkyl ketal ester compound combination, the alkyl ketal ester compound can be used in combination with the antimicrobial agent as a single compound, or can be used in combination with the antimicrobial agent as a mixture of two or more alkyl ketal ester compounds. Particularly beneficial is the combination of an antimicrobial agent with a mixture of ethyl levulinate propylene glycol acetal and ethyl levulinate glycerol acetal or with ethyl levulinate propylene glycol acetal and 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)butyl propionate or with ethyl levulinate glycerol acetal and / or with 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)butyl propionate. Such a combination exhibits a significant synergistic antimicrobial effect against a broad spectrum of microorganisms, i.e., against bacteria, yeasts, and fungi / molds, compared to their single antimicrobial agents.
[0559] The above specific combinations of antimicrobial agents with ethyl levulinate propylene glycol acetal and / or ethyl levulinate glycerol acetal and / or 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionic acid butyl ester are characterized by a synergistic antimicrobial effect against a broad spectrum of microorganisms, i.e. against bacteria, yeasts and fungi / molds, compared to their respective single antimicrobial agents, as demonstrated by the MIC (minimum inhibitory concentration) test in the following examples.
[0560] The synergistic antimicrobial effect is particularly observed for the combination of o-cymene-5-ol and ethyl levulinate propylene glycol acetal and / or ethyl levulinate glycerol acetal and / or butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate.
[0561] Combinations of ethylhexylglycerol and ethyl levulinate propylene glycol acetal and / or ethyl levulinate glycerol acetal and / or butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate are also particularly advantageous.
[0562] Furthermore, when used in combination with different antimicrobial substances, ethyl levulinate propylene glycol acetal and / or ethyl levulinate glycerol acetal and / or butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate in combination with the antimicrobial glyceryl caprylate synergistically reduced the microbial load.
[0563] The synergistic antimicrobial effect is also true for the combination of 4-hydroxyacetophenone with ethyl levulinate propylene glycol acetal and / or ethyl levulinate glycerol acetal and / or butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate.
[0564] A synergistic antimicrobial effect of 1,3-propanediol can also be demonstrated when used in combination with ethyl levulinate propylene glycol acetal and / or ethyl levulinate glycerol acetal and / or butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate.
[0565] The above synergistically enhanced antimicrobial effect is particularly pronounced for combinations with 1,2-alkanediols such as 1,2-pentanediol, 1,2-hexanediol, 1,2-heptanediol, 1,2-octanediol, 1,2-nonanediol and 1,2-decanediol and ethyl levulinate propylene glycol acetal and / or ethyl levulinate glycerol acetal and / or 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionic acid butyl ester, compared to the corresponding individual 1,2-alkanediol substances.
[0566] A synergistic antimicrobial effect can also be observed for 2,3-alkanediol analogs such as 2,3-pentanediol, 2,3-hexanediol, 2,3-heptanediol, 2,3-octanediol, 2,3-nonanediol, and 2,3-decanediol when combined with ethyl levulinate propylene glycol acetal and / or ethyl levulinate glycerol acetal and / or butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate.
[0567] The above combinations comprising an antimicrobial agent and ethyl levulinate propylene glycol acetal and / or ethyl levulinate glycerol acetal and / or 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionic acid butyl ester show significant synergistic antimicrobial activity and are significantly better than the corresponding antimicrobial agent alone at the same concentration.
[0568] Thus, by using this antimicrobial combination according to the invention, the growth of microorganisms in food or cosmetic or pharmaceutical compositions or household care products can be significantly inhibited and the microbial load in such formulations can thus be significantly reduced. Thus, the storage stability of such formulations can be significantly improved and the shelf life can thus be extended. Furthermore, the risk of deterioration during use by individual customers is significantly reduced.
[0569] The synergistic antimicrobial effect of the above combinations of antimicrobial agents and ethyl levulinate propylene glycol acetal and / or ethyl levulinate glycerol acetal and / or butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate allows reducing the amount of antimicrobial agent in the final formulation without losing the antimicrobial effect.
[0570] The specific combinations defined above may be combined with one or more further components (c), such as active substances and / or additives for example for food, cosmetic or pharmaceutical compositions or household care products, as described later.
[0571] In order to further enhance the antimicrobial efficacy, the composition as defined herein is advantageously combined with at least one further antimicrobial agent different from component (a) of the composition according to the invention.
[0572] The combination with other antimicrobial agents provides reliable protection against microbial degradation and deterioration of food or cosmetics or pharmaceutical preparations, particularly during storage. In addition, the other different antimicrobial agents provide reliable protection against other microorganisms as described above, such as Corynebacterium, Anaerococcus, Finegoldia, Moraxella, Porphyromonas, Fusobacterium, Malassezia, Peptoniphilus, Streptococcus, Lactobacillus, Gardnerella, Fannyhessea, Epidermophyton, Trichophyton, Cutibacterium. Thus, the combination with a further different antimicrobial agent allows for antimicrobial protection against a different group of microorganisms and thus allows for antimicrobial protection against a wider spectrum of microorganisms.
[0573] Furthermore, the composition according to the invention may also have different antimicrobial targets, preferably antimicrobial substances for skin protection, by means of additional different antimicrobial agents.
[0574] In the context of the present invention, the other different antimicrobial agents are preferably selected from 2-benzylheptanol, alkyl (C12-22) trimethylammonium bromide and alkyl (C12-22) trimethylammonium chloride, ascorbic acid and its salts, benzalkonium bromide, benzalkonium chloride, benzalkonium saccharinate, benzethonium chloride, benzoic acid, camphor, cetylpyridinium chloride, chlorhexidine diacetate, chlorhexidine dihydrochloride, chlorocresol, chloroxylenol, cyclohexylglycerol, dimethylphenylbutanol, dimethylphenylpropanol, ethanol, 1,2-dimethylphenylpropanol ... Ethyl lauroyl argininate HCl, ethyl lauroyl argininate laurate, eucalyptol, gluconic acid and its salts, glycerin, hexamidine, hexamidine di(hydroxyethylsulfonate), hexylglycerin, iodopropynyl butylcarbamate, jasmol, lauryl alcohol, levulinic acid, mannitol, menthol, methyl salicylate, octenidine HCl, polyarginine, polyglyceryl-10 laurate, polyglyceryl-2 caprate, polyglyceryl-3 caprylate, polylysine, sage (Salvia Officinalis (Sage) oil, silver chloride, silver citrate, sodium caproyl lactylate, sodium caproyl / lauroyl lactylate, sodium lauroyl lactylate, sorbic acid, sorbitol, Tetraselmis extract, triclocarban, triclosan, triethyl citrate, Xylityl Sesquicaprylate, zinc citrate, zinc pyrithione, zinc ricinoleate, and mixtures of two or more of the foregoing antimicrobial agents.
[0575] In a more preferred variant, the other different antimicrobial agent is selected from 2-benzylheptanol, benzoic acid, dimethylphenylbutanol, dimethylphenylpropanol, lauroyl arginine ethyl ester HCl, lauroyl arginine ethyl ester laurate, gluconic acid and its salts, glyceryl laurate, jasmone, lauryl alcohol, levulinic acid, mannitol, octenidine HCl, polyglyceryl-10 laurate, polyglyceryl-2 caprate, polyglyceryl-3 caprylate, clary sage oil, sodium caproyl lactylate, sodium caproyl / lauroyl lactylate, sodium lauroyl lactylate, sorbic acid, sorbitol, Zhou's platycodon extract, triclosan, triethyl citrate, sesquioctanoic acid wood ester, zinc ricinoleate, and mixtures of two or more of the aforementioned antimicrobial agents.
[0576] In the context of the present invention, it is also possible and in some cases advantageous to combine the composition according to the first aspect of the invention with other conventional active substances, adjuvants or additives.
[0577] Optionally, as described further below, further customary cosmetic and / or pharmaceutical active substances, adjuvants or additives may be added as component (c), ie in order to obtain ready-to-use preparations or formulations, such as food, cosmetic or pharmaceutical preparations or preparations for animal care.
[0578] The compositions according to the invention can advantageously be combined with other cosmetically or pharmaceutically active agents and / or adjuvants and / or additives or auxiliaries, such as are conventionally used in such preparations or formulations, such as abrasives, anti-acne agents, anti-skin aging agents, anti-cellulitis agents, anti-dandruff agents, anti-inflammatory agents, irritation prevention agents, irritation inhibitors, antioxidants, astringents, odor absorbers, sweat inhibitors, disinfectants, antistatic agents, adhesives, buffers, carrier materials, chelating agents, cell stimulants, cleaning agents, depilatories, surfactants, deodorants, Antiperspirants, softeners, emulsifiers, enzymes, enzyme inhibitors, essential oils, fibers, film formers, fixatives, foam formers, foam stabilizers, anti-foaming substances, foam boosters, gelling agents, gel formers, hair care agents, hair setting agents, hair straighteners, moisture supply agents, moisturizing substances, moisture retaining substances, bleaching agents, enhancers, stain removers, optical brighteners, impregnants, stain repellents, dyes, friction reducers, lubricants, moisturizers, ointments, sunscreens, plasticizers, covering agents, polishing agents, preservatives, glossing agents, green and synthetic polymers powders, proteins, re-oiling agents, abrasives, silicones, skin soothing agents, skin cleansers, skin care agents, skin healing agents, skin lighteners, skin protectants, skin softeners, hair promoters, cooling agents, skin cooling agents, warming agents, skin warming agents, stabilizers, surfactants, UV absorbers, UV filters, primary sun protection factors, secondary sun protection factors, detergents, fabric conditioners, suspending agents, skin tanning agents, active substances that regulate skin or hair pigmentation, matrix metalloproteinase inhibitors, skin moisturizers, sugar amines Polysaccharide stimulators, TRPV1 antagonists, peeling agents, anti-cellulite agents or fat enhancers, hair growth activators or inhibitors, thickeners, rheological additives, vitamins, oils, waxes, pearlescent waxes, fats, phospholipids, saturated fatty acids, mono- or polyunsaturated fatty acids, alpha anti-hydroxy acids, polyhydroxy fatty acids, liquefiers, dyes, color protectants, pigments, anti-corrosion agents, fragrances or aromatic oils, fragrances, flavoring substances, scented substances, polyols, electrolytes, organic solvents and mixtures of two or more of the above substances, as further described below.
[0579] Among the abovementioned cosmetically or pharmaceutically active agents and / or adjuvants and / or additives or auxiliaries, anti-skin aging agents, antioxidants, chelating agents, emulsifiers, surfactants, green and synthetic polymers, skin cooling agents, rheological additives, oils, fragrances or aromatic oils and polyols are particularly preferred in the preparation of cosmetic and pharmaceutical compositions.
[0580] In some cases, a cosmetically or pharmaceutically active agent and / or adjuvant and / or additive may provide one or more than one benefit or operate via more than one mode of action.
[0581] Since dermatological conditions or diseases are often associated with dry skin, abraded skin, skin damage or even inflammation, the compositions according to the invention advantageously contain preferably anti-inflammatory agents, antibacterial or antifungal substances, substances with a redness-reducing or itching-reducing effect, long-acting substances, moisturizers and / or cooling agents, penetrants, keratolytic substances, nourishing substances, anti-inflammatory, antibacterial or antifungal substances, substances with a redness-reducing or itching-reducing effect, long-acting substances, antidandruff substances or other active compounds such as solvents, fragrances, antioxidants, preservatives, (metal) chelators, penetration enhancers or mixtures of two or more of the aforementioned agents.
[0582] In addition to the abovementioned substances, other ingredients commonly used in the cosmetic or pharmaceutical industry can be used which are suitable or customary in the compositions of the invention.
[0583] The at least one alkyl ketal ester compound, in particular the ethyl levulinate propylene glycol acetal and / or ethyl levulinate glycerol acetal and / or butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate, is present in the composition according to the first aspect of the invention or in the ready-to-use product, i.e. in the finished food or cosmetic or pharmaceutical preparation or home care product, in an amount of 0.001 to 15.0 wt.-%, based on the total weight of the composition or the finished food, cosmetic or pharmaceutical preparation or home care product.
[0584] In a preferred variant, the composition or the final formulation comprises the alkyl ketal ester compound, in particular the ethyl levulinate propylene glycol acetal and / or ethyl levulinate glycerol acetal and / or butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate, in an amount of 0.01 to 10.0 wt.-%, based on the total weight of the composition or the final food, cosmetic or pharmaceutical formulation or household care product.
[0585] In a particularly preferred variant, the alkyl ketal ester compounds, in particular the ethyl levulinate propylene glycol acetal and / or the ethyl levulinate glycerol acetal and / or 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionic acid butyl ester are advantageously used in the composition or the finished formulation in an amount of 0.1 to 5.0 wt.-%, based on the total weight of the composition or the finished food, cosmetic or pharmaceutical formulation or household care product.
[0586] For a mixture of alkyl ketal ester compounds, such as ethyl levulinate propylene glycol acetal and ethyl levulinate glycerol acetal, the above amount refers to the total content of the two compounds in the mixture, that is, the amount is the sum of the contents of ethyl levulinate propylene glycol acetal and ethyl levulinate glycerol acetal in the mixture.
[0587] The antimicrobial component is present in the composition or the finished cosmetic or pharmaceutical formulation according to the invention in an amount of 0.01 to 25.0 wt.-%, based on the total weight of the composition or the finished food, cosmetic or pharmaceutical formulation or household care product.
[0588] In a preferred variant, the composition or the finished cosmetic or pharmaceutical preparation or the home care product comprises the antimicrobial component in an amount of 0.02 to 15.0 wt. %, based on the total weight of the composition or the finished food, cosmetic or pharmaceutical preparation or the home care product.
[0589] In a particularly preferred variant, the antimicrobial component is advantageously used in the composition or the finished food, cosmetic or pharmaceutical preparation in an amount ranging from 0.05 to 6.0% by weight, based on the total weight of the composition or the finished cosmetic or pharmaceutical preparation.
[0590] As demonstrated in the following examples, the alkyl ketal ester compounds significantly improve the antimicrobial efficacy of the antimicrobial component against bacteria, yeasts and fungi / molds in food, cosmetic or pharmaceutical compositions. Surprisingly, the combination of the antimicrobial component as defined above with the alkyl ketal ester compounds according to the invention achieves a synergistic microbial effect.
[0591] A synergistic effect is one achieved when two different chemical substances or biological structures interact to achieve an overall effect that is greater than the sum of any of their individual effects.
[0592] This synergistic effect is particularly achieved for ethyl levulinate propylene glycol acetal or ethyl levulinate glycerol acetal or 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)butyl propionate or a combination of two or three of the levulinate compounds. The use of the compounds alone or in combination significantly increases the antimicrobial effect of the antimicrobial component against bacteria, yeasts and fungi / molds in food, cosmetics or pharmaceutical preparations.
[0593] The synergistic antimicrobial effect has the advantage that the total content of the antimicrobial component in the composition can be reduced by achieving a higher performance of the antimicrobial component with the same amount, or vice versa, by achieving the same performance with a lower amount of the antimicrobial component, thereby broadening the antimicrobial efficacy of the antimicrobial component.
[0594] In a second aspect, the present invention relates to an antimicrobial compound represented by general formula (I) or a derivative thereof
[0595]
[0596] in
[0597] R 1is an optionally substituted C1 to C12 alkyl group or an optionally substituted C1 to C12 alkenyl group;
[0598] R 2 is hydrogen, optionally substituted C1 to C3 alkyl or optionally substituted C1 to C3 alkenyl;
[0599] R 3 , R 4 , R 5 , R 6 and R 7 are each independently hydrogen, optionally substituted C1 to C6 alkyl, or optionally substituted C1 to C6 alkenyl;
[0600] a is 0 or an integer from 1 to 6;
[0601] b is 0 or 1.
[0602] Some of the alkyl ketal ester compounds within the scope of Formula (I) contain one or more chiral carbon atoms. The structure of Formula (I) does not distinguish between those possible stereoisomers, and is intended to include all such stereoisomers.
[0603] In a preferred variant of the general formula (I), R 1 It is an optionally substituted C1 to C6 alkyl group, more preferably an optionally substituted C1 to C4 alkyl group, and most preferably an optionally substituted C1 or C2 alkyl group.
[0604] In a further preferred variant of the general formula (I), R 2 is hydrogen or C1 alkyl, more preferably R 2 It is a C1 alkyl group.
[0605] In a further preferred variant of the general formula (I), R 3 , R 4 , R 5 , R 6 and R 7 Each is independently hydrogen or optionally substituted C1 to C3 alkyl, more preferably optionally substituted C1 alkyl.
[0606] In further preferred variants of the general formula (I), a is an integer from 1 to 6, more particularly an integer from 1 to 4, still more preferably an integer of 2 or 3.
[0607] In still more preferred variants of general formula (I), R 1 is a C1 to C4 alkyl group, R 2 is methyl, R 3 , R 4 and R 5 are each independently hydrogen or C1 to C3 alkyl, R 6 is hydrogen or C1 to C3 alkyl, R 7is hydrogen or optionally substituted C1 to C3 alkyl, a is an integer from 2 to 3, and b is 0 or 1.
[0608] In still more preferred variants of general formula (I), R 1 is a C1 to C4 alkyl group, R 2 is methyl, R 3 , R 4 and R 5 are independently hydrogen, R 5 is hydrogen, R 6 is hydrogen or C1 to C3 alkyl, R 7 is hydrogen or optionally substituted C1 to C3 alkyl, a is an integer of 2, and b is 0 or 1.
[0609] In still more preferred variants of general formula (I), R 1 is a C1 to C4 alkyl group, R 2 is methyl, R 3 , R 4 and R 5 are independently hydrogen, R 5 is hydrogen, R 6 is hydrogen, R 7 is hydrogen, a is the integer 2, and b is 0 or 1.
[0610] In still more preferred variations, the alkyl ketal esters include those having the following structures (II) to (VII):
[0611]
[0612] Where R 1 is methyl, ethyl, n-propyl or n-butyl;
[0613]
[0614] Where R 1 is methyl, ethyl, n-propyl or n-butyl;
[0615]
[0616] Where R 1 is methyl, ethyl, n-propyl or n-butyl;
[0617]
[0618] Where R 1 is methyl, ethyl, n-propyl or n-butyl;
[0619]
[0620] Where R 1is methyl, ethyl, n-propyl or n-butyl; and R 3 is methyl or ethyl; and
[0621]
[0622] Where R 1 It is methyl, ethyl, n-propyl or n-butyl.
[0623] In a most preferred variant according to the second aspect of the invention, the alkyl ketal ester is selected from ethyl levulinate propylene glycol acetal
[0624]
[0625] Ethyl levulinate glycerol acetal
[0626]
[0627] 3-(2,4-Dimethyl-1,3-dioxolan-2-yl)butyl propionate
[0628]
[0629] and mixtures thereof.
[0630] Alkyl ketal ester compounds of the known general formula (I) are excellent formulation ingredients that provide a number of benefits. The alkyl ketal ester compounds are excellent solvents for a wide range of materials, including active agents that can be used in personal care formulations. Many of them are at least partially miscible with water or other organic solvents, or both, that are typically present in, for example, personal care formulations, as well as a wide range of slightly hydrophobic materials. The alkyl ester compounds have low volatility. Under conventional manufacturing, storage and use conditions, the alkyl ketal esters do not react with many other materials that are typically found in, for example, personal care formulations. In addition, the alkyl ketal esters can act as emulsifiers or compatibilizers.
[0631] The alkyl ketal ester compounds as defined herein can be obtained by acid-catalyzed reaction of the corresponding ketoesters with diols, or by transesterification of ketal esters, as described, for example, in US 2014 / 0147395 A1.
[0632] It has surprisingly been found that the alkyl ketal ester compounds according to general formula (I) as defined herein have significant antimicrobial efficacy.
[0633] The antimicrobial compounds of general formula (I) according to the present invention act mainly against microorganisms, in particular bacteria, yeasts and / or fungi. Specific microorganisms are undesirable aerobic mesophilic bacteria or yeasts or fungi in cosmetics, which may be harmful to human health or serve as an indication of sanitary failure in the manufacturing process. Microorganisms considered as specific microorganisms according to the present invention belong to the genera Pseudomonas (bacteria), Staphylococcus (bacteria), Escherichia (bacteria), Candida (yeast) and Aspergillus (fungi), and combinations thereof.
[0634] More preferably, the microorganism is selected from Pseudomonas aeruginosa, Staphylococcus aureus, Escherichia coli, Candida albicans and Aspergillus brasiliensis, and combinations thereof.
[0635] In the most preferred variant according to the second aspect of the invention, among the antimicrobial compounds of general formula (I) as defined herein, the compounds ethyl levulinate propylene glycol acetal, ethyl levulinate glycerol acetal, 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)butyl propionate or a mixture of two or three of said compounds are particularly beneficial because they exhibit unique antimicrobial efficacy.
[0636] The antimicrobial efficacy of the above compounds or their mixtures against microorganisms Pseudomonas aeruginosa, Staphylococcus aureus, Escherichia coli, Candida albicans and Aspergillus brasiliensis is particularly significant.
[0637] The antimicrobial alkyl ketal ester compound, in particular the ethyl levulinate propylene glycol acetal and / or ethyl levulinate glycerol acetal and / or butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate, is present in the ready-to-use product, i.e. in the finished food or cosmetic or pharmaceutical preparation or home care product, in an amount of 0.001 to 15.0 wt.-%, based on the total weight of the finished food, cosmetic or pharmaceutical preparation or home care product.
[0638] In a preferred variant, the final formulation comprises the alkyl ketal ester compound, in particular the ethyl levulinate propylene glycol acetal and / or ethyl levulinate glycerol acetal and / or 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionic acid butyl ester, in an amount of 0.01 to 10.0 wt.-%, based on the total weight of the final food, cosmetic or pharmaceutical formulation or household care product.
[0639] In a particularly preferred variant, the alkyl ketal ester compound, in particular the ethyl levulinate propylene glycol acetal and / or ethyl levulinate glycerol acetal and / or 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionic acid butyl ester is advantageously used in the final formulation in an amount of 0.1 to 5.0 wt.-%, based on the total weight of the final food, cosmetic or pharmaceutical formulation.
[0640] For a mixture of alkyl ketal ester compounds composed of ethyl levulinate propylene glycol acetal and / or ethyl levulinate glycerol acetal and / or 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)butyl propionate, the above amount refers to the total content of the alkyl ketal ester compounds in the mixture, that is, the amount is the sum of the contents of ethyl levulinate propylene glycol acetal and / or ethyl levulinate glycerol acetal and / or 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)butyl propionate in the mixture.
[0641] Due to the described advantageous properties, the antimicrobial composition according to the first aspect of the invention and the antimicrobial alkyl ketal ester compound according to the second aspect of the invention can be used to prepare food, cosmetic or pharmaceutical preparations or home care products, which can thus be microbiologically stabilized. Microbiological stabilization allows the food, cosmetic or pharmaceutical preparations or home care products to be stored without microbial degradation and deterioration, thus improving the shelf life of the food, cosmetic or pharmaceutical preparations or home care products.
[0642] Therefore, in another aspect of the invention, the invention relates to a food, cosmetic or pharmaceutical preparation or a household care product comprising an antimicrobial composition according to the invention or an antimicrobial compound as defined herein.
[0643] The cosmetic or pharmaceutical (especially dermatological) composition according to the invention is intended for topical application. The term "topical" is understood to mean external application on mammalian skin, in particular for the treatment, protection, care and cleansing of the skin, scalp, eyelashes, eyebrows, nails, mucous membranes and hair. The mammal is preferably a human.
[0644] For topical application, the cosmetic or pharmaceutical preparation is a rinse-off or leave-on preparation.
[0645] The cosmetic or pharmaceutical (in particular dermatological) preparations according to the invention can be present in different forms, for example in the form of a dispersion, in the form of a liquid surfactant formulation, in the form of a solid surfactant formulation or in the form of an aqueous solution, an aqueous / alcoholic solution, in particular an aqueous / ethanolic solution, or an aqueous / glycolic solution.
[0646] In a preferred variant, the cosmetic or pharmaceutical preparation according to the invention is a dispersion. In the context of the present invention, the term "dispersion" means that the cosmetic or pharmaceutical preparation is a dispersed two-phase system consisting of colloidal particles (dispersed phase) and the medium in which they are suspended (dispersion medium). The two phases are immiscible with each other and are only miscible with the emulsifier. Such a dispersion, such as an emulsion, contains an oil component in an amount of preferably ≥1% by weight, more preferably ≥3% by weight.
[0647] If the cosmetic or pharmaceutical preparation according to the invention is a dispersion, preferably an emulsion, the oil component is present in the cosmetic or pharmaceutical preparation in an amount of 0.01% to 50.0% by weight, based on the total weight of the composition. In a preferred variant, the cosmetic or pharmaceutical preparation contains an oil component in an amount of 1.0 to 40.0% by weight, based on the total weight of the composition. In a particularly preferred variant, the oil component is advantageously used in the cosmetic or pharmaceutical preparation in an amount of 3.0 to 30% by weight, based on the total weight of the composition.
[0648] Preferably, the cosmetic or pharmaceutical preparation according to the first aspect or the second aspect of the present invention takes various forms, such as emulsions, in particular O / W emulsions, W / O emulsions, multiple emulsions, water-dispersible gels, balms, water-in-oil (W / O / WO) or oil-in-water (O / W / O) multiple emulsions, PIT emulsions, Pickering emulsions, microemulsions, liquids, lotions, suspensions, milks, ointments, pastes, gels, cream-based formulations, oil-based formulations or liposome-based formulations.
[0649] In a further alternative, the cosmetic or pharmaceutical preparation according to the invention is a liquid surfactant formulation.
[0650] Such liquid surfactant formulations include, for example, shampoos, shower gels, micellar waters, liquid soaps, cleaning preparations.
[0651] If the cosmetic or pharmaceutical preparation according to the present invention is a liquid surfactant composition, the surfactant component is present in the cosmetic or pharmaceutical preparation in an amount of 1 to 40% by weight, preferably 3 to 30% by weight, more preferably 5 to 25% by weight, based on the total weight of the composition.
[0652] In a further alternative, the cosmetic or pharmaceutical preparation according to the invention is a solid surfactant formulation.
[0653] Such solid surfactant formulations include, for example, solid shampoos, solid body washes, bar soaps.
[0654] Alternatively, and particularly preferably, the cosmetic or pharmaceutical preparation disclosed herein is a solution based on water or water / alcohol or water / glycol. The solution based on water / alcohol or water / glycol contains an aliphatic alcohol or glycol in an amount of 0.1 to ≤50% by weight based on the total weight of the solution. The aliphatic alcohol is preferably selected from ethanol, isopropanol, n-propanol. The glycol is preferably selected from glycerol, propylene glycol, butylene glycol or dipropylene glycol. Preferably, the total water content in the final composition of such a composition can be ≥60%, more preferably ≥70%, even more preferably ≥80%, even more preferably ≥90%, and preferably ≥90% in special cases. New applications such as those including water wipes have a high water content. In a specific variant, the composition of the present invention can be used for such wet wipe applications. Then they can most preferably contain ≥95% water, or even ≥98% water.
[0655] Such water or water / alcohol or water / glycol based solutions include, for example, deodorant / antiperspirant roll-ons, aftershaves, cleansing formulations, anti-acne formulations or wet wipe solutions.
[0656] In a preferred variant, the cosmetic or pharmaceutical preparation according to the invention is in the form of an emulsion as defined herein, advantageously an oil-in-water (O / W) emulsion comprising an oily phase dispersed in an aqueous phase in the presence of an O / W emulsifier.
[0657] In the most preferred variant, the cosmetic or pharmaceutical preparation according to the invention is in the form of a solution based on water or water / alcohol, preferably water / ethanol, or water / glycol. Typically, this can be glycerol in an aqueous composition.
[0658] The above-described cosmetic or pharmaceutical preparations of the formulations are prepared according to customary and known methods.
[0659] In a preferred variant, the cosmetic preparations according to the invention are preparations for cosmetic and / or non-therapeutic use in personal care, skin protection, skin care, scalp protection, scalp care, hair care, nail care, in particular for the prevention and / or treatment of skin disorders, intolerances or sensitive skin, skin irritations, skin redness, rosacea, wheals, itching (pruritus), skin aging, wrinkle formation, loss of skin volume, loss of skin elasticity, pigmented spots, dyspigmentation, dry skin, flaking, oiliness, skin hypopigmentation and / or hyperpigmentation; or for animal care.
[0660] Examples of personal care are preferably anti-aging preparations, skin care lotions, body oils, body lotions, cleansing lotions, face or body balms, after shave balms, after sun balms, deodorant lotions, cationic lotions, body gels, treatment creams, skin protection ointments, moisturizing gels, face and / or body moisturizers, photoprotective preparations (sunscreens), micellar waters, hair sprays, color-protecting hair products, skin lightening products, anti-dark spot preparations, etc.
[0661] The home care products according to the present invention are primarily detergent formulations, typically liquids, powders, sprays, granules or tablets, which are used to remove dirt, including dust, stains, bad odors and debris on surfaces, or other types of household cleaning or laundry detergents added for cleaning clothes or liquid soap. Typical home care products include all-purpose cleaners, dishwashing detergents, hard floor and surface cleaners, glass cleaners, carpet cleaners, oven cleaners, laundry detergents, fabric softeners, laundry fragrances, fragrance washes, car shampoos, edge block gels, car shampoos or furniture polishes, all of the above also in encapsulated form or air fresheners.
[0662] Due to their outstanding antimicrobial efficacy, the composition according to the first aspect of the invention and the antimicrobial compound according to the second aspect of the invention are suitable for the preservation of food, cosmetic or pharmaceutical preparations or household care products.
[0663] Therefore, in another aspect, the present invention relates to the use of the composition according to the first aspect of the invention and the antimicrobial compound according to the second aspect of the invention for preventing or inhibiting the growth of microorganisms in food, cosmetics or pharmaceutical preparations. Here, the composition and the novel antimicrobial compound of the invention are valuable in ensuring good preservation of the products. Preventing or inhibiting the growth of microorganisms is a reduction in the growth rate of microorganisms and / or a stagnation or reduction in the number of viable microorganisms. By preventing or inhibiting the growth of microorganisms, degradation and deterioration of the cosmetic or pharmaceutical preparation can be prevented or at least minimized, especially during storage, which degradation and deterioration are sometimes accompanied by impairment of the organoleptic quality of the product.
[0664] A use is further preferred, wherein the microorganism is selected from Staphylococcus, Candida, Aspergillus, Pseudomonas and Escherichia and combinations thereof, particularly selected from Staphylococcus aureus, Candida albicans, Aspergillus braziliensis, Pseudomonas aeruginosa, Escherichia coli and combinations thereof, more particularly Candida albicans and Aspergillus braziliensis. The antimicrobial composition according to the first aspect of the present invention and the antimicrobial compound according to the second aspect of the present invention show excellent efficacy against these microorganisms.
[0665] Surprisingly, it has been found that the combination of ethyl levulinate propylene glycol acetal or ethyl levulinate glycerol acetal or butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate with an antimicrobial agent as defined herein synergistically enhances its antimicrobial action.
[0666] Therefore, the present invention relates in another aspect to the use of an alkyl ketal ester compound according to the invention, preferably ethyl levulinate propylene glycol acetal and / or ethyl levulinate glycerol acetal and / or butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate, for improving the efficacy of an antimicrobial component, preferably in a food, cosmetic or pharmaceutical preparation.
[0667] Due to the above-mentioned advantageous properties resulting from the use of alkyl ketal ester compounds, preferably ethyl levulinate propylene glycol acetal and / or ethyl levulinate glycerol acetal and / or 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionic acid butyl ester, the amount of antimicrobial agent in food, cosmetic or pharmaceutical preparations can be reduced.
[0668] Finally, the present invention also relates to a method for preventing or inhibiting the growth of microorganisms in a food, cosmetic or pharmaceutical preparation or a home care product, as defined herein. In the method according to the invention, a food, cosmetic or pharmaceutical preparation or a home care product is provided. Next, an effective amount of an antimicrobial composition according to the first aspect of the invention or an antimicrobial compound according to the second aspect of the invention is incorporated into the food, cosmetic or pharmaceutical preparation or home care product, thereby achieving the preservation of the product.
[0669] The present invention will now be described in detail with reference to the following examples, which are only used to exemplify the present invention, and the contents of the present invention are not limited to or by the following examples.
[0670] Example
[0671] Example 1
[0672] The minimum inhibitory concentration (MIC) test is a test for growth inhibition. The estimation of MIC is performed in 96-well plates. Different concentrations of a given test substance are evaluated by comparing bacterial growth with positive and negative controls via optical density (OD).
[0673] Bacteria were cultured under adapted conditions based on information from the German Collection of Microorganisms and Cell Cultures (DSMZ) and stored in 10% or 50% glycerol before use. Then, the following method was applied: Growth medium (according to the microorganism) was added to each well of the microplate. Then, test substances dissolved in DMSO, positive controls (water controls with culture medium only), solvent controls (DMSO controls with culture medium only) and negative controls (benchmarks according to the organism) were added in different concentrations. Finally, 1 to 6 × 10 6The microorganisms are added at a concentration of CFU / ml (CFU=colony forming units). The microplates are incubated under appropriate conditions.
[0674] Depending on the growth obtained, substance concentrations were marked as inhibitory or non-inhibitory, and the MIC was defined as the lowest concentration at which complete growth inhibition was seen. Experiments were performed at least twice at the concentration limits (highest concentration marked as growth and lowest concentration marked as inhibition).
[0675] The synergistic activity of NxtSolv 320 (ethyl levulinate propylene glycol acetal) and Nxt Solv 420 (ethyl levulinate glycerol acetal) with different antimicrobial compound combinations was determined by measuring the minimum inhibitory concentration (MIC) according to the method described above. The concentrations tested were typically: 10,000 ppm series between 100,000 and 50,000 ppm, 5,000 ppm series between 50,000 ppm and 10,000 ppm, 2,500 ppm series below 10,000 ppm and 2,500 ppm, and 1,000 ppm. In special cases, intermediate dilution series were performed to further improve the MIC resolution. Pure ethyl levulinate propylene glycol acetal samples showed no effect against Pseudomonas aeruginosa up to 100,000 ppm, and the MIC was set to 100,000 to determine possible synergistic effects.
[0676] To verify the synergistic effect of the tested combinations against microorganisms, corresponding experiments were performed with Staphylococcus aureus, Candida albicans, Aspergillus brasiliensis, Pseudomonas aeruginosa and Escherichia coli. The synergistic activity of ethyl levulinate propylene glycol acetal and ethyl levulinate glycerol acetal and different antimicrobial compounds in 50% and 50% mixtures was determined by measuring the MIC of the mixtures.
[0677] To calculate the synergy index from the MIC values, the following Kull equation was used:
[0678] SI=(MIC 混合物 ×P A ) / MIC A +(MIC 混合物 ×P B ) / MIC B
[0679] in
[0680] SI is based on Kull's Synergy Index
[0681] MIC A is the MIC value of substance A
[0682] MIC B is the MIC value of substance B
[0683] MIC 混合物 is the MIC value of the mixture of substances A and B
[0684] P A is the proportion of substance A in the mixture
[0685] P B is the proportion of substance B in the mixture
[0686] Example 1.1: MIC values and synergistic index of the combination of ethyl levulinate propylene glycol acetal and 4-hydroxyacetophenone against Staphylococcus aureus, Candida albicans, Aspergillus brasiliensis, Pseudomonas aeruginosa and Escherichia coli
[0687] Table 1:
[0688]
[0689] For the tested antimicrobial components, a synergistic effect was found with respect to antimicrobial efficacy: SI values were below 1. For a 50%:50% mixture of ethyl levulinate propylene glycol acetal and 4-hydroxyacetophenone, the respective MIC values were determined, yielding a synergistic index of 0.81 for Staphylococcus aureus, 0.54 for Candida albicans, 0.13 for Aspergillus braziliensis, and 0.65 for Pseudomonas aeruginosa. For Candida albicans and Aspergillus braziliensis, the combination can achieve the best synergistic effect. This means that by adding ethyl levulinate propylene glycol acetal, the concentration of the antimicrobial component can be reduced while the same antimicrobial effect can be obtained. Therefore, the use of ethyl levulinate propylene glycol acetal allows the use of less antimicrobial components in food, cosmetic or pharmaceutical compositions or home care products to achieve the same antimicrobial effect, compared to food, cosmetic or pharmaceutical compositions or home care products containing the same antimicrobial component but without the use of ethyl levulinate propylene glycol acetal.
[0690] Example 1.2: MIC values and synergistic index of the combination of ethyl levulinate propylene glycol acetal and Hydrolite 5green against Staphylococcus aureus, Candida albicans, Aspergillus brasiliensis, Pseudomonas aeruginosa and Escherichia coli
[0691] Table 2:
[0692]
[0693] For the tested antimicrobial components, a synergistic effect with respect to antimicrobial efficacy was found: SI values were below 1. For a 50%:50% mixture of ethyl levulinate propylene glycol acetal and pentanediol (1,2-pentanediol), the respective MIC values were determined, resulting in a synergistic index of 0.20 against Aspergillus braziliensis and a synergistic index of 0.54 against Pseudomonas aeruginosa. For Aspergillus braziliensis, the combination can achieve the best synergistic effect. This means that by adding ethyl levulinate propylene glycol acetal, the concentration of the antimicrobial component can be reduced while the same antimicrobial effect can be obtained. Therefore, the use of ethyl levulinate propylene glycol acetal allows the use of less antimicrobial components in food, cosmetic or pharmaceutical compositions or home care products to achieve the same antimicrobial effect, compared to food, cosmetic or pharmaceutical compositions or home care products containing the same antimicrobial components but without the use of ethyl levulinate propylene glycol acetal.
[0694] Example 1.3: MIC values and synergistic index of the combination of ethyl levulinate propylene glycol acetal and ethylhexylglycerol against Staphylococcus aureus, Candida albicans, Aspergillus brasiliensis, Pseudomonas aeruginosa and Escherichia coli
[0695] Table 3:
[0696]
[0697] For the tested antimicrobial components, a synergistic effect was found with respect to antimicrobial efficacy: the SI value was less than 1. For a 50%:50% mixture of ethyl levulinate propylene glycol acetal and ethylhexylglycerol, the respective MIC values were determined, yielding a synergistic index of 0.45 for Pseudomonas aeruginosa and a synergistic index of 0.55 for Escherichia coli. For Pseudomonas aeruginosa, the combination can achieve the best synergistic effect. This means that by adding ethyl levulinate propylene glycol acetal, the concentration of the antimicrobial component can be reduced while the same antimicrobial effect can be obtained. Therefore, the use of ethyl levulinate propylene glycol acetal allows the use of fewer antimicrobial components in food, cosmetic or pharmaceutical compositions or home care products to achieve the same antimicrobial effect, compared to foods, cosmetics or pharmaceutical compositions or home care products containing the same antimicrobial components but without the use of ethyl levulinate propylene glycol acetal.
[0698] Example 1.4: MIC values and synergistic index of the combination of ethyl levulinate glycerol acetal and 4-hydroxyacetophenone against Staphylococcus aureus, Candida albicans, Aspergillus brasiliensis, Pseudomonas aeruginosa and Escherichia coli
[0699] Table 4:
[0700]
[0701] For the tested antimicrobial components, a synergistic effect was found with respect to antimicrobial efficacy: SI values were below 1. For a 50%:50% mixture of ethyl levulinate glycerol acetal and 4-hydroxyacetophenone, the respective MIC values were determined, yielding a synergistic index of 0.96 for Staphylococcus aureus, 0.52 for Candida albicans, 0.58 for Aspergillus braziliensis, and 0.70 for Pseudomonas aeruginosa. For the fungi Candida albicans and Aspergillus braziliensis, the combination can achieve the best synergistic effect. This means that by adding ethyl levulinate glycerol acetal, the concentration of the antimicrobial component can be reduced while the same antimicrobial effect can be obtained. Therefore, the use of ethyl levulinate glycerol acetal allows the use of less antimicrobial components in food, cosmetic or pharmaceutical compositions or home care products to achieve the same antimicrobial effect, compared to food, cosmetic or pharmaceutical compositions or home care products containing the same antimicrobial components but without the use of ethyl levulinate glycerol acetal.
[0702] Example 1.5: MIC values and synergistic index of the combination of ethyl levulinate glycerol acetal and cinnamyl alcohol against Staphylococcus aureus, Candida albicans, Aspergillus brasiliensis, Pseudomonas aeruginosa and Escherichia coli
[0703] Table 5:
[0704]
[0705] For the tested antimicrobial components, a synergistic effect with respect to antimicrobial efficacy was found: SI values were below 1. For a 50%:50% mixture of ethyl levulinate glycerol acetal and 1,2-pentanediol, the respective MIC values were determined, resulting in a synergistic index of 0.93 against Aspergillus brasiliensis, 0.62 against Pseudomonas aeruginosa, and 0.93 against Escherichia coli. For Pseudomonas aeruginosa, the combination can achieve the best synergistic effect. This means that by adding ethyl levulinate glycerol acetal, the concentration of the antimicrobial component can be reduced while the same antimicrobial effect can be obtained. Therefore, the use of ethyl levulinate glycerol acetal allows the use of less antimicrobial components in food, cosmetic or pharmaceutical compositions or home care products to achieve the same antimicrobial effect, compared to food, cosmetic or pharmaceutical compositions or home care products containing the same antimicrobial components but without the use of ethyl levulinate glycerol acetal.
[0706] Example 1.6: MIC values and synergistic index of the combination of ethyl levulinate glycerol acetal and ethylhexylglycerol against Staphylococcus aureus, Candida albicans, Aspergillus brasiliensis, Pseudomonas aeruginosa and Escherichia coli
[0707] Table 6:
[0708]
[0709] For the tested antimicrobial components, a synergistic effect was found with respect to the antimicrobial efficacy: the SI values were below 1. For a 50%:50% mixture of ethyl levulinate glyceryl acetal and ethylhexylglycerol, the respective MIC values were determined, resulting in a synergistic index of 0.55 against Escherichia coli. This means that the combination is particularly effective against Escherichia coli. This means that by adding ethyl levulinate glyceryl acetal, the concentration of the antimicrobial component can be reduced while the same antimicrobial effect can be obtained. Therefore, the use of ethyl levulinate glyceryl acetal allows the use of less antimicrobial components in food, cosmetic or pharmaceutical compositions or home care products to achieve the same antimicrobial effect, compared to food, cosmetic or pharmaceutical compositions or home care products comprising the same antimicrobial components but without the use of ethyl levulinate glyceryl acetal.
[0710] Formulation Examples
[0711] The following formulations according to the invention were prepared:
[0712] ■Cream O / W
[0713] ■Hand and body cream
[0714] ■Daily face cream, SPF 20
[0715] ■Body lotion
[0716] ■ Sprayable antibacterial body lotion
[0717] ■Barrier repair cream
[0718] ■Skin Soothing Lotion
[0719] ■Baby Diaper Rash Cream (w / o)
[0720] ■Sunscreen (o / w; broad spectrum protection)
[0721] ■Sunscreen soft cream (w / o), SPF 40
[0722] ■ Clear Anti-Acne Wipes
[0723] ■PEG-free wet wipes
[0724] ■Baby Soft Wet Wipes
[0725] ■Private wipes
[0726] ■Aftershave wipes
[0727] ■Biological Acne Control Gel
[0728] ■ Anti-wrinkle gel
[0729] ■ Cleansing Micellar Gel
[0730] ■Transparent beard gel
[0731] ■ Sprayable anti-cellulite gel
[0732] ■Aloe Vera Gel
[0733] ■Anti-dandruff shampoo
[0734] ■Rinse-off conditioner
[0735] ■Solid shampoo
[0736] In the following formulation examples, the following five fragrance oils PFO1, PFO2, PFO3, PFO4 or PFO5 were each used as fragrance.
[0737] Table F1: Composition of aromatic oil 1; PO1 (amount in ‰, by weight)
[0738]
[0739]
[0740]
[0741] Table F2: Composition of aromatic oil 2; PO2 (amount in ‰ weight)
[0742]
[0743]
[0744] Table F3: Composition of aromatic oil 3; PO3 (amount in ‰ weight)
[0745]
[0746]
[0747] Table F4: Composition of aromatic oil 4; PO4 (amount by weight in ‰)
[0748]
[0749]
[0750] Table F5: Composition of aromatic oil 5; PO5 (amount in ‰, by weight)
[0751]
[0752]
[0753] Cosmetic Formulations (Compositions) - For all formulations, amounts are expressed as % by weight.
[0754] Table F6: Cream o / w
[0755]
[0756]
[0757] Table F7: Hand and body creams
[0758]
[0759]
[0760] Table F8: Daily face cream SPF20
[0761]
[0762]
[0763] Table F9: Body Lotion
[0764]
[0765]
[0766] Table F10: Sprayable antibacterial body lotion
[0767]
[0768]
[0769] Table F11: Barrier Repair Cream
[0770]
[0771]
[0772]
[0773] Table F12: Skin Soothing Lotion
[0774]
[0775]
[0776] Table F13: Baby Diaper Rash Cream (w / o)
[0777]
[0778]
[0779] Table F14: Sunscreen lotion (o / w; broad spectrum protection)
[0780]
[0781]
[0782] Table F15: Sunscreen soft cream (w / o), SPF40
[0783]
[0784]
[0785] Table F16: Transparent Anti-Acne Wipes
[0786]
[0787] Table F17: Wet wipes without PEG
[0788]
[0789] Table F19: Baby Soft Wet Wipes
[0790]
[0791]
[0792] Table F19: Intimate Wipes
[0793]
[0794]
[0795] Table F20: Aftershave wipes
[0796]
[0797]
[0798] Table F21: Biological Acne Control Gel
[0799]
[0800]
[0801] Table F22: Anti-wrinkle gel
[0802]
[0803]
[0804] Table F23: Cleansing Micellar Gel
[0805]
[0806]
[0807] Table F24: Transparent Beard Gel
[0808]
[0809]
[0810] Table F25: Sprayable Anti-Cellulite Gel
[0811]
[0812] Table F26: Aloe Vera Gel
[0813]
[0814] Table F27: Anti-dandruff shampoo
[0815]
[0816]
[0817] Table F28: Rinse-off Conditioner
[0818]
[0819]
Claims
1. A composition comprising or consisting of: (a) an effective amount of at least one antimicrobial agent; (b) an effective amount of an alkyl ketal ester compound represented by the general formula (I) or a derivative thereof in R 1 is an optionally substituted C1 to C12 alkyl group or an optionally substituted C1 to C12 alkenyl group; R 2 is hydrogen, optionally substituted C1 to C3 alkyl or optionally substituted C1 to C3 alkenyl; R 3 , R 4 , R 5 , R 6 and R 7 are each independently hydrogen, optionally substituted C1 to C6 alkyl, or optionally substituted C1 to C6 alkenyl; a is 0 or an integer from 1 to 6; b is 0 or 1; as well as (c) optionally at least one active substance and / or additive for a food, cosmetic or pharmaceutical composition or a household care product.
2. The composition according to claim 1, wherein the compound of general formula (I) is selected from compounds (II) to (VII): Where R 1 is methyl, ethyl, n-propyl or n-butyl; Where R 1 is methyl, ethyl, n-propyl or n-butyl; Where R 1 is methyl, ethyl, n-propyl or n-butyl; Where R 1 is methyl, ethyl, n-propyl or n-butyl; Where R 1 is methyl, ethyl, n-propyl or n-butyl; and R 3 is methyl or ethyl; and Where R 1 It is methyl, ethyl, n-propyl or n-butyl.
3. The composition according to claim 1 or claim 2, wherein the compound is selected from: ethyl levulinate propylene glycol acetal Ethyl levulinate glycerol acetal 3-(2,4-Dimethyl-1,3-dioxolan-2-yl)butyl propionate and mixtures thereof.
4. The composition according to any one of claims 1 to 3, wherein the at least one antimicrobial component (a) is selected from o-cymene-5-ol, isopropyl paraben, capryloyl glycine, phenylpropanol, tropolone, PCA cocoyl arginine ethyl ester salt, 2-methyl-5-cyclohexylpentanol, phenoxyethanol, disodium EDTA, methyl paraben and its salts, capryloyl hydroxamic acid, sodium benzoate, benzyl alcohol, potassium sorbate, salicylic acid Benzyl Ester, Methyl Benzyl Alcohol, Propylparaben, Methylchloroisothiazolinone, Methylisothiazolinone, Ethylhexylglycerin, Butylparaben, Ethylparaben, Sodium Propylparaben, DMDM Hydantoin, Dehydroacetic Acid, Iodopropynyl Butylcarbamate, Salicylic Acid, Chlorphenesin, Isobutylparaben, Sodium Ethylparaben, Diazolidinyl Urea, Farnesol, Bisabolol, Sodium Phytate or Phytic Acid, Levulinic Acid Sodium or levulinic acid, chlorhexidine, glyceryl laurate, anisic acid and its salts, chlorhexidine digluconate, TEA-salicylate, phenethyl alcohol, hexylene glycol, glyceryl caprate, sorbitan caprylate, tetrasodium glutamate diacetate, trisodium ethylenediamine disuccinate, hydroxyethoxyphenyl butanone, hydroxyethoxyphenyl butanol, itaconic acid, pyridone ethanolamine salt, propylene glycol caprylate, climbazole, undecylenyl glycine, undecylenic acid, thymol, glyceryl Oleic acid octanoate, 4-hydroxyacetophenone, sodium lactate, trisodium dicarboxymethyl alanine, 1,3-propylene glycol, 1,2-pentanediol, 1,2-hexanediol, 1,2-heptanediol, 1,2-octanediol, 1,2-nonanediol, 1,2-decanediol, 2,3-pentanediol, 2,3-hexanediol, 2,3-heptanediol, 2,3-octanediol, 2,3-nonanediol, 2,3-decanediol, and mixtures of two or more of the foregoing antimicrobial agents.
5. The composition according to any one of claims 1 to 4, further comprising at least one antimicrobial agent different from the antimicrobial component (a), selected from 2-benzylheptanol, alkyl (C12-22) trimethylammonium bromide and alkyl (C12-22) trimethylammonium chloride, ascorbic acid and its salts, benzalkonium bromide, benzalkonium chloride, benzalkonium saccharinate, benzethonium chloride, benzoic acid, camphor, cetylpyridinium chloride, chlorhexidine diacetate, chlorhexidine dihydrochloride, chlorocresol, chloroxylenol, cyclohexylglycerol, dimethylphenylbutanol, dimethylphenylpropanol, ethanol, lauroyl arginine ethyl ester HCl, lauroyl arginine ethyl ester laurate, eucalyptol, gluconic acid and its salts , glycerin, hexamidine, hexamidine di(hydroxyethyl sulfonate), hexylglycerin, iodopropynyl butylcarbamate, jasmone, lauryl alcohol, levulinic acid, mannitol, menthol, methyl salicylate, octenidine HCl, polyarginine, polyglyceryl-10 laurate, polyglyceryl-2 caprate, polyglyceryl-3 caprylate, polylysine, clary sage oil, silver chloride, silver citrate, sodium caproyl lactylate, sodium caproyl / lauroyl lactylate, sodium lauroyl lactylate, sorbic acid, sorbitol, zhou's chrysanthemum extract, triclocarban, triclosan, triethyl citrate, sesquioctanoic acid lignylate, zinc citrate, zinc pyrithione, zinc ricinoleate, and mixtures of two or more of the foregoing antimicrobial agents.
6. A composition according to any one of claims 1 to 5, wherein the at least one active substance for food, cosmetic or pharmaceutical compositions or household care products is selected from anti-skin aging agents, antioxidants, chelating agents, emulsifiers, surfactants, green and synthetic polymers, skin cooling agents, rheological additives, oils, spices or aromatic oils, polyols and mixtures of two or more of the above substances.
7. A composition according to any one of claims 1 to 6, comprising the antimicrobial component (a) in an amount of 0.01 to 25.0 wt.-%, particularly in an amount of 0.02 to 15.0 wt.-%, most particularly in an amount of 0.05 to 6.0 wt.-%, based on the total weight of the composition.
8. The composition according to any one of claims 1 to 7, comprising the alkyl ketal ester compound (b), preferably ethyl levulinate propylene glycol acetal and / or ethyl levulinate glycerol acetal and / or butyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl-)propionate, in an amount of 0.001 to 15.0 wt.-%, particularly in an amount of 0.01 to 10.0 wt.-%, most particularly in an amount of 0.1 to 5.0 wt.-%, based on the total weight of the composition.
9. Antimicrobial compounds represented by general formula (I) or derivatives thereof in R 1is an optionally substituted C1 to C12 alkyl group or an optionally substituted C1 to C12 alkenyl group; R 2 is hydrogen, optionally substituted C1 to C3 alkyl or optionally substituted C1 to C3 alkenyl; R 3 , R 4 , R 5 , R 6 and R 7 are each independently hydrogen, optionally substituted C1 to C6 alkyl, or optionally substituted C1 to C6 alkenyl; a is 0 or an integer from 1 to 6; b is 0 or 1.
10. The antimicrobial compound according to claim 9, wherein the compound is selected from: ethyl levulinate propylene glycol acetal Ethyl levulinate glycerol acetal 3-(2,4-Dimethyl-1,3-dioxolan-2-yl)butyl propionate and mixtures thereof.
11. A food, cosmetic or pharmaceutical preparation or a household care product comprising a composition according to any one of claims 1 to 8 or an antimicrobial compound according to claim 9 or claim 10.
12. The cosmetic or pharmaceutical preparation according to claim 9 i. in the form of a dispersion comprising the oil component in an amount of ≥1 wt.-%, in particular in an amount of ≥3 wt.-%, in particular, preferably in the form of an emulsion, in particular an O / W emulsion, a W / O emulsion, a multiple emulsion, an aqueous dispersion gel, a balm, a water-in-oil (W / O / W) or oil-in-water (O / W / O) multiple emulsion, a PIT emulsion, a Pickering emulsion, a microemulsion, a liquid, a lotion, a suspension, a milk, an ointment, a paste, a gel, a cream-based preparation, an oil-based preparation or a liposome-based formulation; ii. in the form of a liquid surfactant formulation; iii. in the form of a solid surfactant formulation; iv. Aqueous or aqueous / alcoholic forms, in particular aqueous / ethanolic solutions, or aqueous / glycolic solutions; in particular, wherein the cosmetic or pharmaceutical preparation is a cold formulation composition.
13. Use of a composition according to any one of claims 1 to 8 or an antimicrobial compound according to claim 9 or claim 10 for preventing or inhibiting the growth of microorganisms in food, cosmetic or pharmaceutical preparations or household care products.
14. The method according to claim 13, wherein the microorganism is selected from the group consisting of Pseudomonas, Staphylococcus, Escherichia, Candida, Aspergillus and combinations thereof, in particular selected from the group consisting of Pseudomonas aeruginosa, Staphylococcus aureus, Escherichia coli, Candida albicans and Aspergillus braziliensis and combinations thereof, more particularly Candida albicans and Aspergillus braziliensis.
15. Use of an alkyl ketal ester compound according to general formula (I) as defined in any one of claims 1 to 3, preferably ethyl levulinate propylene glycol acetal and / or ethyl levulinate glycerol acetal, for enhancing the efficacy of an antimicrobial component as defined in claim 4 or claim 5.
16. A method for preventing or inhibiting the growth of microorganisms in food, cosmetics or pharmaceutical preparations, comprising the following steps: - supply of food, cosmetic or pharmaceutical preparations or household care products; - Incorporated therein an effective amount of an antimicrobial composition as defined in any one of claims 1 to 8 or an antimicrobial compound as defined in claim 9 or claim 10.
Citation Information
Patent Citations
Carboxy ester ketals, methods of manufacture, and uses thereof
US20140147395A1
